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Abstract 
Methylation of CpG dinucleotides is the major epigenetic modification of mammalian 
DNA  which  results  in  the  remodelling  of  transcriptionally  active  euchromatin  to 
transcriptionally  inactive  heterochromatin.    Recognition  of  methylated  CpG  by 
methylated DNA binding proteins, the MBD family, the Kaiso zinc finger family and the 
SRA domain proteins results in deacetylation and methylation of histone side chains 
through  the  recruitment  of  HDAC  and  HMT  enzymes.    Methylation  of  DNA  is  a 
heritable process ensuring Methylation dependant transcriptional repression is passed 
from mother to daughter cell during replication.  Some of the proteins involved in this 
chromatin  remodelling,  MBD1,  DNMT1,  MLL,  and  CFP1  contain  CXXC  domains.  
hMBD1 contains 2 or 3 CXXC domains depending on the splice variant, with only the 
third CXXC domain shown to bind CpG dinucleotides.     
 
This thesis describes the work done to elucidate the structure of hMBD1 CXXC1 and to 
investigate  hMBD1  CXXC12  di-domain  by  NMR  spectroscopy  and  biochemical 
characterisation.   The hMBD1 CXXC1  & CXXC12 domains were successfully over 
expressed in E. coli and purified.  Unlabelled and uniformly 
15N labelled proteins were 
produced for nuclear magnetic resonance (NMR) studies.  Assignment of NMR spectra 
was carried out and constraints generated enabling structure determination of hMBD1 
CXXC1 and to investigate the relationship between CXXC1 and CXXC2 of hMBD1.  
 
The  solution  structure  of  hMBD1  CXXC1  determined  here  was  compared  to  the 
previously determined solution structure of hMLL CXXC in order to investigate their 
differences  in  DNA  binding.    NOE  data  from  hMBD1  CXXC1  and  CXXC12  are 
compared in order to investigate the domain structure of CXXC12.  DNA titration of 
hMBD1 CXXC1 showed no significant interaction with a single CpG oligo while the 
loop region of hMBD1 CXXC1 differs significant in both structure and surface charge 
suggesting the loop region to be important for DNA binding.  The recorded NOE data of 
hMBD CXXC12 suggests the two CXXC domains form a globular rather than a linear 
structure      
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1.1 Epigenetics 
Epigenetics  is  the  study  of  heritable  changes  in  gene  function  that  occur  without  a 
change  in  the  sequence  of  nuclear  DNA.    This  form  of  inheritance  allows  the 
transmission of information from mother to daughter cell without the information being 
encoded in the nucleotide sequence of the gene, for example when a liver cell divides, 
the daughter cells do not start to express proteins specific to muscle cells.  Methylation 
of  a  CpG  dinucleotide  at  cytosine  C5  (mCpG)  is  a  major  epigenetic  gene  silencing 
modification  in  vertebrate  genomes.    This  modification  recruits  proteins  which 
specifically recognise this motif.  These methylated DNA binding proteins then recruit 
enzymes which chemically and physically alter chromatin, which induces transcriptional 
repression.  Although most CpG motifs are methylated it should be noted that short 
(500-2000bp) CG-rich regions, known as CpG islands, found within 60% of human gene 
promoters remain non-methylated (Bird, A. 2002).   While this is true for normal cells, 
de novo methylation of CpG islands occurs in various cancers, inducing silencing of 
tumour suppressor genes e.g. CDH1 in breast, bladder and prostate cancer (Graff et al. 
1995), CDKN2A in many epithelial cancers (Merlo et al. 1995), and the Rb gene in 
retinoblastomas (Sakai et al. 1991). 
 
Control  of  gene  expression/repression  is  important  in  cell  development  and 
differentiation to ensure that only cell-specific genes are transcribed. Some genes are 
constitutively  transcribed  in  almost  all  cells,  e.g.  Glyceraldehyde  3  phosphate 
dehydrogenase (GAPDH); some genes are only transcribed in certain cell types, e.g. 
carnitine palmitoyltransferase I C in rat brain and testes (Price et al, 2002); others are 
only transcribed after a signaling cascade has been initiated, e.g. induction of insulin 
gene transcription by glucose in beta cells of the Islets of Langerhans (Leibiger et al. 
1998).   Eukaryotic DNA is packaged into a nucleoprotein complex called chromatin 
that  is  organized  into  two  structurally  distinct  domains,  euchromatin  and 
heterochromatin (Heitz, 1928). Euchromatin is condensed during cell division but more 
open  and  transcriptionally  active  during  interphase  while  heterochromatin  is  tightly 
packed and transcriptionally inactive throughout the cell cycle.  While there is only one 
class  of  euchromatin,  heterochromatin  has  two  variants,  constitutive  or  facultative.  
Constitutive heterochromatin is fixed, irreversible and located at very specific spots in 
the genome that consist of DNA that contains many tandem (not inverted) repeats of a 
short repeating unit known as satellite DNA.  Facultative heterochromatin can revert to a 
euchromatin state for example, when a woman transmits the X-chromosome to a son; it   16 
reverts  to  euchromatin  from  heterochromatin.      Replication  of  these  two  types  of 
chromatin  occurs  at  different  time  points,  with  heterochromatic  DNA  late  and 
euchromatic  DNA  early  within  the  cell  cycle  (Gilbert,  2002).    DNA  methylation  is 
functionally connected to these two states through histone modification.  In a simplified 
view,  euchromatic  DNA  contains  non-methylated  CpGs  and  the  histones  are  often 
acetylated whereas the CpGs in heterochromatin DNA are methylated and the histones 
are deacetylated with methylation occurring at histone 3 lysine 9 (H3K9
m) (Cameron et 
al. 1999).  De-methylation of CpG motifs allows H3K9
m to be re-acetylated (Bachman 
et al. 2003) which ultimately leads to a switch from hetero- to euchromatic DNA.  Thus 
DNA methylation is a pivotal signal for the epigenetic control of gene expression in a 
reversible heritable manner. 
 
1.2 Chromatin Structure 
The Basic building blocks of Chromatin are five types of proteins called histones which 
contain  a  high  proportion  of  charged  amino  acids.      These  histones  fall  into  two 
categories, the nucleosomal histones and the H1 histones.  The nucleosomal group is 
made up of four histones which are called H2A, H2B, H3, H4 and their variants.  They 
are small proteins 102-135aa with H3 and H4 histones being among the most highly 
evolutionally conserved of all proteins.  The H1 histones are larger, approx 220aa, and 
are less conserved than the nucleosomal group.   Although histones are the building 
blocks of chromatin, there are also architectural proteins that are comprised of acidic or 
non-histone chromatin proteins. 
 
The 11 nm diameter nucleosome (Fig.1.1), the fundamental building block of chromatin, 
is a complex comprised of an 146 bp (base pair) length of DNA wrapped around an 
octomer core of histone proteins consisting of two copies each of H2A, H2B, H3, and 
H4 (Richmond et al. 1984, Dorigo et al. 2004).   
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Figure 1.1  X-ray crystal structure of the nucleosome core particle solved by Luger et 
al  (1997).  Ribbon traces for the 146-bp DNA phosphodiester backbones (Yellow) and 
eight histone protein main chains (orange: H3; red: H4; green: H2A; blue: H2B).  Image 
generated from PDB ref 1AO1 (Figure prepared using PyMol).    18 
With a small length, 10-100bp, of DNA (linker) between each nucleosome, this type of 
chromatin  thread  can  be  visualized  by  electron  microscopy  which  gives  rise  to  the 
‘beads  on  a  string’  structure  description.  The  H1  histone  protein  binds  to  a  specific 
region of the nucleosome and mediates the packing of the 11nm nucleosome into a 30nm 
chromatin fibre.  From this 30nm fibre the DNA can be condensed into a chromosome. 
The histones also possess N- and C- terminal tails, 14-38aa in length, that protrude from 
the nucleosome (Luger et al. 1997) and direct the formation of higher-order chromatin 
structures (Dorigo et al. 2003, Dorigo et al. 2004, Gordon et al. 2005). 
 
As mentioned previously not all proteins associated with chromatin are histones.  These 
non-histone  architectural  proteins  are  responsible  for  the  chromatin  regulatory 
mechanisms  such  as  covalent  histone  modifications  or  ATP-dependent  chromatin 
remodeling (Cosgrove et al. 2004, Smith & Peterson, 2004, Studisky et al. 2004).  The 
packing of chromatin at its lower level is defined by DNA-histone and nucleosome-
nucleosome interactions.  Chromatin remodeling at specific loci is carried out through 
tagging of the histone tails (Fig 1.2a). Covalent modification of the histone tails in the 
form of acetylation and methylation are important for the remodeling of chromatin to 
activate and repress transcription respectively (Berger, 2001, Strahl and Allis, 2000).  
Other covalent modifications include phosphorylation, ubiquitylation, sumoylation (Gill, 
2004) and ADP-ribosylation (Cohen-Armon et al. 2004) (fig 1.2b) 
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Histone deacetylation (H3K9) by histone deacetylase enzymes (HDAC) and methylation 
of the same residue by histone methyl transferases (HMT) (Fuks et al. 2003) can be 
brought about by the binding of methylated DNA binding proteins to methyl-CpG motifs 
which recruit HDACs to chromatin (Nan X et al. 1998).    The methylation of H3K9 
allows the binding of heterochromatin protein 1 (HP1) via its chromodomain (Banister et 
al. 2001) which stabilizes the formation of heterochromatin and induces transcriptional 
repression.    DNMT1  also  binds  the  HDACs  HDAC1  (Robertson  et  al.  2000)  and 
HDAC2 (Rountree et al, 2000) via its N-terminal domain.  DNMT1 binding to HDAC2 
is  associated  with  binding  to  another  protein,  DMAP1  (DNMT1  associated  protein) 
which can mediate transcriptional repression (Rountree et al. 2000).  It should also be 
noted that loss of DNMT1 from DNMT1 knockout human cancer cells KO1 results in an 
increase of H3 acetylation and loss of trimethylation of lysine 9.  Also HDACs and HP1 
no longer interact with histone H3 and pericentrometric
 repetitive sequences (Espada et 
al. 2004).  This suggests that DNMT1 contributes more to heterochromatin formation 
than just the methylation of CpG motifs. 
Figure 1.2  a Diagram of the 11 nm beads on a string chromatin conformation 
showing histone tails. b The various histone tail covalent modifications. A , acetyl ;  P, 
phosphate;  M, methyl;  Ub, Ubiqutin; C, carboxy terminus; N, amino terminus.  
Adapted from Marks et al (2001)    20 
1.3 DNA Methylation 
Methylation is the major covalent modification of eukaryotic DNA and almost always 
found  in  a  palindromic  CpG  sequence  such  that  the  5  methyl  cytosine  is  found 
symmetrically on both strands (Sinsheimer 1955).  Methylated DNA was first proposed 
by Scarano (1971) and later by Holliday & Pugh (1975) and Riggs (1975) to be involved 
in cell differentiation and gene function.  Later Yeivin and Razin (1993) showed that 
epigenetic control of gene expression in mammals involves DNA methylation associated 
with gene-specific methylation patterns.  Methylation occurs at 70-80% of mammalian 
CpG sites (Ehrlich and Wang 1981) with the remaining unmethylated CpG sites being 
found in CpG rich islands.  CpG islands have been shown to be present at promoter 
regions of all constitutively expressed and approximately 40% of tissue specific genes 
(Larsen et al, 1992. Zhu et al, 2008).  However, not all CpG islands are non-methylated, 
some  of  which  are  involved  in  X-inactivation  and  genomic  imprinting  (Edwards  & 
Ferguson-Smith, 2007., Reik, 2007) 
 
Without the replacement of methylated cytosines, DNA replication would remove 50% 
of  methylated  CpG  from  DNA  after  two  rounds  of  replication  through  passive 
demethylation.  In order to protect the symmetrical methylation of CpG, the enzyme 
DNA methyl transferase (DNMT1) catalyses the covalent attachment of a methyl group 
to the naked cytosine in a hemi-methylated CpG (Bestor and Ingram 1983). DNMT1 is 
associated  with  proliferating  cell  nuclear  antigen  during  DNA  replication  at  the 
replication foci, with methylation occurring within one to two minutes of replication to 
restore a state of full methylation to the DNA (Chuang et al. 1997).  It is through this 
process  that  methylated  DNA  induced  gene  repression  is  inherited  from  mother  to 
daughter for many generations of actively dividing cells (Razin and Riggs 1980).   
 
The reason that CpG Islands are not methylated at replication could be explained by 
their replication during G1/early S phase (Delgado et al. 1998) when DNMT1 levels are 
low (Szyf et al, 1991) and levels of the transcription factor p21 are high which could 
out-compete DNMT1 for binding to PCNA (Chuang et al. 1997).   This could prevent 
DNMT1  being  present  at  the  replication  foci  of  CpG  islands  thus  preventing  their 
methylation.  This theory is strengthened by the fact that many CpG islands are also 
replication origins (Delgado et al. 1998) and, due to the proteolytic factors involved in 
DNA replication, could block DNMT1 access to the DNA. However, it does not explain 
the lack of methylated CpG islands that are located in the promoters of genes that lack   21 
p21 recognition sites.  Recently the CXXC Finger Protein 1 (CFP1), a component of the 
SET1 H3K4 methyltransferase complex (Skalnik et al, 2008), has been shown to bind 
CpG islands (Thompson et al, 2010).   Methylation of H3K4 is  a euchromatic mark 
associated with transcriptional activity (Bernstein et al, 2002., Santos-Rosa et al, 2002., 
Schneider  et  al,  2004).    Therefore  the  recruitment  of  CFP1  to  CpG  islands  and 
subsequent methylation of H3K4 may prevent methylation through steric interference.   
 
It has been reported that methylated DNA does undergo active demethylation (Oswald et 
al, 2000) but this is not necessarily associated with replication (Kafri et al. 1992) while 
the paternal genome in fertilized mouse eggs is stripped of DNA methylation prior to 
zygotic fusion and subsequent replication (Mayer et al. 2000).  This demethylation of 
the paternal genome is a feature of mouse, rat, human and pig zygotes but surprisingly 
not of rabbit and sheep zygotes (Beaujean et al. 2005, Beaujean et al. 2004a, Young & 
Beaujean, 2004).  Interestingly the sheep paternal genome is significantly demethylated 
when injected into mouse oocytes (Beaujean et al. 2004b) suggesting it is not inherently 
resistant to demethylation.  While DNMT1 is responsible for maintaining methylation 
patterns during DNA replication, de novo methylation at previously unmethylated sites 
during early embryogenesis is catalyzed by DNMT3a & DNMT3b (Okano et al. 1999).  
However, DNMT1 can be stimulated to methylate CpG dinucleotides by the addition of 
fully methylated DNA (Fatami et al, 2001, Laing et al, 2001).  DNMT1 is essential for 
mouse embryogenesis as targeted knockouts of DNMT1 results in death around mid 
gestation (Li et al. 1992, Bird & Wolffe, 1999). This is also true for Xenopus laevis 
embryos which die before mid-blastula transition if DNMT1 is knocked out (Stancheva 
& Meehan, 2000).  However, this is independent of DNMT1’s methyltransferase activity 
(Dunican et al, 2008)      
 
Aberrant DNA methylation is of particular importance in cancer (Jones & Baylin, 2002) 
as  hypomethylation  can  result  in  the  inappropriate  expression  of  genes  while 
hypermethylation of CpG islands can switch off genes (Jones & Baylin, 2002, Feinberg 
& Vogelstein, 1983).  Hypermethylation of CpG islands found in tumor suppressor gene 
promoters  is  a  prevalent  mechanism  for  the  transcriptional  silencing  of  these  genes 
(Robertson, 2001, Rountree  et al. 2001. Esteller  & Herman, 2002., Jones  &  Baylin, 
2002.).  Removal of methyltransferase activity from the human colorectal cancer cell 
line  HCT116  by  genetic  (antisense/siRNA  against  DNMT1  RNA)  or  pharmacologic 
methods  (5-aza-2'-deoxycytidine)  causes  extensive  hypomethylation  throughout  the   22 
genome,  including  hypermethylated  regions  (Robert  et  al.  2003,  Ting  et  al.  2004).  
However, controversy surrounds the question of knocking out DNMT1 is sufficient for 
this  observed  hypomethylation  event.    Ting  et  al.  (2004)  suggest  that  DNMT1  is 
redundant due to a compensatory role for DNMT3b.  In order to investigate this they 
produced a double knockout of DNMT1 & DNMT3b cells which showed greater than 
95% reduction in genomic methylation and crucially these cells re-expressed the tumour 
suppressor gene Cdkn2a, providing a direct link between the methylation of its promoter 
and  its  transcription.    These  double  knockout  cells  had  a  90%  reduction  in  growth 
compared to the wild type HCT116 cells.  DNMT1 might also be targeted to methylate 
DNA  at  Histone  H3-K9  methylated  chromatin  via  interaction  with  the  histone 
methyltransferase SUV39H1 (Fuks et al. 2003).  
 
Females contain two copies of the X chromosome compared the male having just one. In 
order  to  compensate  for  this  random  inactivation  of  one  copy  occurs  during  early 
development  (Lyon,  1961).    This  inactivation  is  associated  with  widespread  DNA 
methylation  (Heard  et  al.  1997),  while  transcription  of  genes  on  the  inactive 
chromosome can be reactivated when cells are treated by inhibitors of DNA methylation 
(Boumil & Lee, 2001).  Not all gene transcription on the inactive X chromosome is 
silenced as some CpG islands remain unmethylated (Heard et al. 1997). 
DNA methylation plays a critical role in genomic imprinting, the phenomenon whereby 
a small subset of all the genes in the genome are expressed according to their parent of 
origin (Bartolomei & Tilghman, 1997).  The control the reciprocal parental gene for 
almost all imprinted genes identified to date is associated with differentially methylated 
regions (Paulsen & Ferguson Smith, 2001).   
 
Thus DNA methylation states play an important role in the transcriptional repression of 
genes, regulation of chromatin structure and the development of embryos while aberrant 
DNA methylation can cause disease, including cancer & developmental disorders, and 
death during gestation.   
 
1.4 Methylated DNA binding proteins 
MeCP2,  MBD1,  MBD2,  MBD3  and  MBD4  constitute  a  family  of  proteins  which 
contain the methyl-CpG-binding domain  (MBD).   In the late 1980s a nuclear factor 
called  MeCP1  (Methyl  CpG  binding  Protein)  was  discovered.    This  factor  could 
discriminate between DNA molecules that contained 12 or more methylated CpG pairs   23 
and unmethylated DNA in band shift assays (Meehan et al. 1989). MeCP1 is a large 
multi-subunit protein complex and has been shown to be comprised of MBD3 (Zhang et 
al.  1999),  the  Mi2/NuRD  complex  and  MBD2  (Ng  H  et  al.  1999,  Feng  and  Zhang  
2001).  More recently other methyl-CpG binding proteins have been discovered.  The 
zinc finger proteins Kaiso (Daniel and Reynolds, 1999., Prokhortchouk et al, 2001), 
ZBTB4 and ZBTB38 (Filion et al, 2006) and UHRF1 & -2 that contain an SRA (SET 
and Ring finger-associated) domain (Unoki et al, 2004).   The first well characterized 
member of the MBD family is MeCP2.   
 
1.4.1 MeCP2    
Identified in 1992, MeCP2  is a 53kDa protein capable of binding one methyl-CpG pair 
(Lewis et al. 1992) although it is suggested that, in vitro, a flanking run of 4 or more A/T 
base pairs (Klose et al. 2005) enhances the affinity.  This is backed up by analysis of the 
binding sites in two of its known targets, Bdnf and Dlx6, which show the methyl-CpG 
site flanked by an A/T greater than 4 motifs (Klose & Bird 2006).  Levels of MeCP2 
protein vary depending on cell type with rat brain containing the highest followed by 
kidney, spleen, liver with the lowest found in testes (Nan X et al. 1993).  Although 
widespread, MeCP2 is not a major repressor of gene regulation (Tudor et al. 2002) but 
binds to loci not targeted by other MBDs (Klose et al. 2005).  However, these reports 
used cultured neurons from embryonic or immature mice where MeCP2 levels are low.  
Skene et al (2010) determined the binding pattern in mature mouse brains which showed 
a different pattern, with MeCP2 tracking the methyl-CpG density of the genome.  These 
results suggest, in mature mouse brain, that MeCP2 is a global regulator of chromatin 
structure.   
 
The MBD domain, defined as the minimum required to bind methyl-CpG, comprises 
amino acids 78-162.  This MBD domain has similar characteristics of the full length 
protein when binding methyl-CpG DNA in that it will bind a single methyl-CpG motif in 
duplex DNA and has negligible binding to hemimethylated DNA or 5-methylcytosine at 
non-CpG motifs (Nan  X et al. 1993).  Within mouse EB28/10  cells,  MeCP2 shows 
punctate labeling, co-localising with heterochromatin when transiently over expressed.  
This  localisation  to  the  chromatin  is  dependant  on  methylation,  as  over  expressed 
MeCP2 in MTase mutant (methylase negative) mouse ES cells produced diffuse nuclear 
staining  with  only  20%  localizing  to  chromatin  (Nan  X  et  al.  1996).    The  small 
percentage of MeCP2 binding to chromatin is likely to be due to the lower levels of   24 
methyl-CpG remaining (Nan X et al. 1996) and non specific DNA binding (Nan X et al. 
1993).     Once bound to methylated CpG, MeCP2 initiates transcriptional repression by 
recruiting  the  transcriptional  co-repressor  Sin3  and  histone  deacetylase  (HDAC) 
complex (Nan X et al. 1998).  Binding of the HDAC is via a transcriptional repression 
domain (Nan X et al. 1997) and is localized to amino acids 207–310 (Yu et al. 2000).  
Removal of the acetyl group from histone H3 lysine 9 (Nan X et al. 1998) facilitates the 
methylation  of  the  same  residue  by  a  histone  methyltransferase  (HMT)  (Fuks  et  al. 
2003).  Treatment with trichostatin A (an inhibitor of HDAC), however, does not fully 
remove transcriptional repression which suggests that MeCP2 can repress by another 
pathway (Yu et al. 2000) or interaction with other complexes that do not require HDAC 
to inhibit transcription. 
    
 
1.4.2 MBD1 
Cross et al. (1998) identified MBD1 (formerly PCM1) by searching the XREF database 
for sequences homologous to the MBD of MeCP2. MBD1 was shown to bind methyl-
CpG via its MBD.  MBD1 was originally thought to be part of the MeCP1 complex 
(Cross et al. 1998).  However, Huck-Hui et al. (2000) showed that MeCP1 band shift 
assays were not affected when MBD1 was immunoprecipitated using a sheep antibody 
against MBD1 amino acids 351-556 from the extract.  As well as the N-terminal MBD 
domain, MBD1 also contains, depending on alternative splicing, 2 or 3 CXXC domains 
(Fujita et al, 1999, Jørgensen et al, 2004).  There are a total of 8 known isoforms of 
MBD1 with the number and type of CXXC domains shown in figure 1.3 
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Figure  1.3  schematic  representations  of  MBD1  splice  variants  with  different 
combinations  of  CXXC  domains.    A:  represents  isoforms  1,  2,  6,  8;  B:  represents 
isoforms 3, 4 ,7; C: isoform 5 (formerly known as PCM1). 
 
A  subunit  of  CAF-1  (chromatin  assembly  factor  1),  p150,  and  SUV39h1,  a 
methyltransferase enzyme both interact with the MBD (Fujita et al. 2003b, Resse et al. 
2003).  It is thought that MBD1 is displaced from methyl-CpG during replication but 
that through its interaction with CAF-1 via PCNA, it remains at the replication fork 
during  S-phase.    Once  replication  has  occurred,  DNMT1  activity  fully  methylates 
hemimethylated CpG motifs allowing MBD1 to rebind to the methyl-CpG (Sarraf & 
Stancheva, 2004) (Fig. 1.4)  
 
Like MeCP2, MBD1 contains a transcriptional repression domain which, when fused to 
the  Gal4  DNA  binding  domain,  can  repress  transcription  from  a  Gal  containing 
promoter.  The transcriptional repression domain (TRD) is known to interact with a 
methyl-DNA  glycosylase  (Watanabe  et  al.  2003)  and  MCAF  (MBD1-containing 
chromatin associated factor) (Fujita N et al. 2003a).   Although MBD1 does not appear 
to  interact  with  HDAC1  or  HDAC2  (Ng  H  et  al.  2000)  there  is  variable  repression 
sensitivity when cells are treated with the HDAC inhibitor trichostatin A (Ng H et al. 
2000, Fujita N et al. 2003a) suggesting that MBD1 induced repression does not always 
require HDACs 
 
Although  MBD1  knock  out  mice  have  been  produced,  the  MBD1
-/-  mice  show  no 
detectable development defects and appear physically healthy throughout their life span.  
However,  adult  knockout  mice  show  decreased  neurogenesis  and  impaired  spatial 
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CXXC 
TRD  MBD  1          2          
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learning, while neural stem cells exhibited reduced neural differentiation and increased 
genomic instability (Zhao et al. 2003). 
 
 
 
 
 
 
 
 
1.4.3 MBD2 
MBD2  was  identified  by  Hendrich  &  Bird  (1998)  by  searching  for  putative  MBD 
domains in the EST database.  It has two possible isoforms depending on translation 
from the first (MBD2a, 43.5 kDa) or second (MBD2b, 29.kDa) ATG codon.    The 
translation from the second ATG codon produces a protein with the MBD at the extreme 
N-terminus (Hendrich & Bird, 1998) lacking the glycine rich region found in MBD2a 
(figure 1.5).    
 
 
 
 
Figure 1.4.  Model summarizing the function of MBD1 complexes in  
transcriptional repression and DNA replication-coupled maintenance of histone 
H3-K9 methylation. MBD1 and H3-K9 methylase SETDB1 form a stable 
MBD1/SETDB1 complex detectable throughout the cell cycle in G1, S, and G2 
(Reproduced from Sarraf & Stancheva, 2004)   27 
 
 
Figure 1.5. Schematic representation of the two isoforms of MBD2. 
 
It was proposed that MBD2b has DNA demethylase activity (Bhattacharya et al. 1999) 
but subsequent attempts by Ng et al. (1999) and Wade et al. (1999) were unable to 
reproduce  these  results.    Like  MeCP2,  transcriptional  repression  via  MBD2  occurs 
through histone modification and it was proposed that MDB2 is part of the MeCP1 
complex  (Ng  et  al.  1999)  which  comprises  MBD3  (Zhang  Y  et  al.  1999)  and  the 
Mi2/NuRD complex (Feng Q and Zhang Y 2001). Recently however, Guezennec et al. 
(2006) have suggested that MBD2/Nurd and MBD3/Nurd are two distinct complexes.  
Evidence  to  further  back  up  Guezennec’s  results  is  shown  in  MBD2  and  MBD3 
knockout mice.  While MBD3
-/- mice die during early embryogenesis, MBD2
-/- mice are 
viable  and  fertile  suggesting  distinct  but  overlapping  roles  for  MBD2  &  MBD3.  
Although MBD2
-/- mice are viable, they show a lack of maternal instinct that results in 
reduced  pup  weight  (Hendrich  et  al.  2001).    When  MBD2
-/-  mice  are  crossed  with 
Apc
min/+ mice, the offspring show reduced adenoma and extended life span compared to 
normal Apc
min/+ mice (Berger & Bird. 2005).   
 
It has been shown that MBD2 interacts with the NuRD complex via a 633 aa protein 
called p66 (Brackertz et al. 2002).  This interaction between p66 and MBD2 has been 
shown to involve two domains.  In p66 aa134-238 (CR1) & aa372-633 (CR2), with the 
second sequence also containing a Zinc finger GATA domain.  In MBD2 the domains 
aa27-45 and aa211-262 bind p66 in a pull down assay (Brackertz et al. 2002).  The 
MeCP1 complex also contains p68 which has high amino acid similarity to p66.  p68 
also  interacts  with  MBD2  but  only  through  the  highly  conserved  CR1  N-terminal 
binding site.   
 
1.4.4 MBD3 
Human MBD3 is a 265 amino acid 32.2kDa protein with an N-terminal MBD domain 
and a C-terminus rich in acidic residues.  It is has a high sequence similarity to MBD2b 
MBD  Glycine rich 
MBD2a 
MBD 
MBD2a   28 
although unlike other members of the MBD family it does not bind methyl-CpG in vitro 
or localize with major satellite DNA in vivo (Hendrich & Bird. 1998).  Similarly it does 
not possess DNA demethylase activity (Wade et al. 1999).   Unlike the human form, 
Xenopus laevis xMBD3 binds methyl-CpG (Wade et al. 1999).  Xenopus laevis also 
expresses an isoform xMBD3LF, a product of alternative spicing with a sequence of 20 
amino acids inserted in the MBD domain, which cannot bind methyl-CpG (Wade et al. 
1999).  xMBD3 is expressed constitutively in the early stages of development with high 
levels detected in the prospective eye regions, brain, and branchial arches.  Suppression 
of xMBD3 in early development severely effects eye formation and brain development 
(Iwano et al. 2004).  Although MBD3 does not bind methyl-CpG it does co-purify with 
the histone remodeling complex Mi-2/NuRD (Guezennec et al. 2006). This coupled with 
the fact that MBD3
-/- knockout mice are non-viable, dying during early embryogenesis 
(Hendrich  et  al.  2001),  suggests  that  MBD3  plays  an  important  role  in  early 
development like that of xMBD3.  While the MBD domain of MBD3 does not bind 
methyl-CpG  it  does  bind  HDAC  and  metastasis-associated  gene  2  (MTA2)  (Saito  & 
Ishikawa,  2002).    This  suggests  that  MBD3  has  conserved  its  MBD  because  of  the 
secondary role played by the MBD in protein-protein interactions. 
 
1.4.5 MBD4 
MBD4  was  identified  at  the  same  time  as  MBD2  and  MBD3  by  Hendrich  &  Bird 
(1998).  This 62.6kDa protein has its MBD domain at the N-terminus and lacks the 
CXXC domains of MBD1.  Like MBD1, MBD2 and MECP2, MBD4 can also bind to 
one symmetrically methylated CpG.  The MBD is most similar to that of MeCP2 in 
sequence and the protein shows little homology to the other MBD family members out 
with the MBD domain. MBD4 does however share a low scoring match to bacterial 
DNA  repair  enzymes.    (Hendrich  &  Bird,  1999).    As  well  as  the  N-terminal  MBD 
domain, MBD4 contains a C-terminal DNA glycosylase catalytic domain  (Hendrich & 
Bird, 1999, Bellacosa et al. 2005) and it has been shown that MBD4 is a thymine and 
uracil glycosylase specific for G-T and G-U mismatches resulting from the deamination 
of  5-methylcytosine  and  cytosine,  respectively,  at  CpG  sites  (Hendrich  et  al.  1999).  
MBD4 is expressed in many human tissues and MBD4-GFP constructs co-localise to the 
foci of heavily methylated satellite DNA (Hendrich & Bird, 1998).  Results from MBD4 
deficient mice suggest that MBD4 suppresses tumorigenesis and CpG mutability in vivo 
as there is an increase in CpG￿TpG mutation and accelerated tumor formation in cancer 
susceptible Apc
min/+ mice (Miller et al. 2002).   29 
 1.4.6 MBD domain structures 
There several MBD domain structures that have been deposited in the protein data bank.  
The solution structure of MBD1 MBD (Ohki et al. 1999), MBD1 MBD in complex with 
DNA (Ohki et al, 2001), solution structure of MeCP2 MBD (Wakefield et al. 1999) and 
the crystal structure of MeCP2 MBD in complex with DNA (Ho et al, 2008) have been 
solved. The NMR derived structures for MBD1 MBD and MeCP2 MBD show similar 
structures  consisting  of  a  wedge  shaped  fold  with  four  anti-parallel  β-strands  which 
constitute one face of the wedge.  Comparison of the crystal structure of MeCP2 in 
complex with DNA (PDB 3C21) and the unliganded NMR structure of MeCP2 (PDB 
1QK9) illustrated in figure 1.6 reveals little difference apart from the loop (L1) where 
most of the protein to DNA sugar-phosphate backbone contacts are made.  While there 
is only moderate homology between MBD1 and MeCP2 there are conserved residues 
within the MBD of the whole family.  It is likely that the MBD of MBD2, MBD3 and 
MBD4  have  similar  structures.    The  lack  of  binding  to  methyl-CpG  by  mammalian 
MBD3 can be attributed to two amino acid differences within the defined MBD domain, 
a phenylalanine at position 34 in place of a tyrosine and a histidine at position 30 in 
place  of  an  arginine  (MBD1  &  MBD4)  or  a  lysine  (MBD2  &  MeCP2)  (Saito  &, 
Ishikawa.  2002).  The  effect  of  the  F34  difference  has  the  greatest  effect  on  mCpG 
binding.  This is not surprising due to the interaction of the tyrosine side chain hydroxyl 
group hydrogen bonding to structural water groups that are involved in the protein-DNA 
interaction. 
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Figure 1.6  Superposition of unbound MeCP2 (green) and MeCP2 bound to DNA 
(yellow).  Methyl-cytosine (sticks) shown as cyan on DNA shown in orange (ribbon), 
Tyrosine 34 shown in red (sticks) and the structural water shown as a black sphere. N, 
N-terminus. Image generated in pymol.   
 
1.4.7 The Zinc finger family of methyl-CpG binding proteins 
The  first  member  of  the  zinc  finger  family  of  mCpG  binding  proteins,  Kaiso,  was 
identified by a yeast 2 hybrid screen for p120 catenin (Daniel and Reynolds, 1999) and 
is a component of the NCoR corepressor complex binding via its BTB domain (Yoon et 
al, 2003) Kaiso contains three tandem zinc fingers at the C-terminus that recognize two 
consecutive  symmetrical  CpG  sequences.  In  cultured  cells,  Kaiso  recruits  the  NCoR 
complex  to  the  MTA2  promoter  when  methylated.    This  results  in  transcriptional 
repression with H3 K9 being deacetylated and methylated (Yoon et al, 2003).  Although 
in normal cells there is presently no information about the target of Kaiso, it is essential 
for amphibian development.  When embryonic levels of the Xenopus Kaiso homologue, 
xKaiso (Kim et al, 2002), are depleted by morpholino oligos, premature activation of   31 
zygotic  genes  occurs  before  the  mid-blastula  transition,  resulting  in  failure  of 
gastrulation and death (Ruzov et al, 2004).  Kaiso also binds to a non-methylated DNA 
sequence,  TCCTGCNA,  known  as  a  Kaiso-Binding  Sequence  (KBS)  (Daniel  et  al, 
2002). This KBS sequence has been found in the promoter of matrilysin (Spring et al, 
2005) and the 5’ beta-globin insulator (Defossez et al, 2005).  The proteins ZBTB4 & 
ZBTB38 (Filion et al, 2006) contain a homologous Kaiso zinc finger domain, which also 
contain a BTB domain but also have additional zinc fingers making them longer and 
more complex.  Unlike Kaiso, the ZBTB proteins can bind a single methylated-CpG 
which may be due to sequence differences compared to Kaiso within the 3
rd Kaiso like 
zinc finger although their in vivo targets are as yet unknown.  ZBTB38 has been shown 
to recruit CtBP to the densely methylated pericentrometric heterochromatin (Sasai et al, 
2005).   CtBP is a corepressor which has also been found to interact with the CXXC 
domain  from  MLL  (Mixed  Linkage  Leukemia)  (Xia  et  al,  2003)  and  can  induce 
transcriptional repression by recruiting  HDACs (Subramanian & Chinnadurai, 2003).  
Unlike  ZBTB38,  ZBTB4  lacks  the  CtBP  interaction  site  and  the  BTB  domain  is 
disrupted by a long serine-rich insertion (Perez-Torrado et al, 2006). 
 
1.4.8 Methylated CpG binding by the SRA domain 
 UHRF1  was  originally  identified  by  Hopfner  et  al  (2000)  as  CCAAT  box  binding 
protein before Unoki and co workers (2004) showed that UHRF1 could bind methylated 
CpG  with  higher  affinity.    The  SET  and  Ring  finger  associated  (SRA)  domain  of 
UHRF1 is responsible for recognizing a single methylated CpG and interacting with 
HDAC1  (Unoki  et  al,  2004).    Recently  Bostick  et  al  (2007)  showed  UHRF1  has  a 
preference  for  hemi-methylated  DNA  and  that  UHRF1  co-localizes  with 
heterochromatin replication foci and interacts with DNMT1 & PCNA, suggesting a role 
in the transfer of heritable transcriptional repression similar to that of MBD1.   
 
1.5 Epigenetic Disease 
Many  cellular  processes  including  embryonic  development,  transcription,  chromatin 
structure, X chromosome inactivation, genomic imprinting and chromosome stability are 
controlled by epigenetic mechanisms.  Any disruption to these processes will have a 
profound effect on the cell and the organism. A common disruption in humans (1:10,000 
births) is Rett Syndrome, a complex neurological disorder mainly affecting girls who 
become profoundly and multiply disabled.  In a large proportion of patients this has been 
linked to mutations in MeCP2 (Amir et al, 1999).  Epigenetic disruption is common in   32 
many  cancers  with  the  tumour  cells  displaying  global  hypomethylation  but  having 
hypermethylated  CpG  islands  in  conjunction  with  histone  modifications  that 
repress/silence tumour suppressor genes (Fahrner et al. 2002, Ballestar et al. 2003).   
 
1.5.1 Rett syndrome  
Rett  syndrome  is  both  sporadic  and  familial  in  origin  with  various  mutations  found 
within  the  gene  responsible  for  its  aberrant  activity.  Amir  et  al.  (1999)  identified 
missense mutations within the highly conserved MBD region as well as missense and 
frame  shift  mutations  within  the  TRD  region  while  further  novel  mutations  were 
identified by Wan et al. (1999) & Cheadle et al. (2000).   A recent review by Matijevic 
at al (2009) noted that 67% of all MeCP2 mutations are caused by a C>T mutation at 
8CpG sites (R106, R133, T158, R168, R288, R270, R294 and R306) the most common 
of which is R168X.     
 
The various mutations of MeCP2 (nonsense, missense, and frame shift) vary the level of 
functionality that the protein has.  Nonsense and frame shift mutations in the 5’ region 
are likely to lead to unstable transcripts through
 the process of nonsense-mediated decay 
(Dragich et al. 2000) while several missense mutation show reduced binding to mCpG in 
vitro (Ballestar et al. 2000).  Two common mutations, R106W & R133C, are located 
within the β-sheet (Wakefield et al. 1999) and show 100 fold reduction in affinity for 
binding methylated DNA in unassembled chromatin (Ballestar et al, 2000).  However in 
native  mouse  heterochromatin  only  R106W  had  markedly  reduced  binding,  whereas 
R133C  showed  wild-type-like  affinity  and  increased  repression  of  a  non-methylated 
reporter construct in Drosophila cells (Kudo et al. 2001). This increased affinity for non-
methylated CpG in the R133C mutant may be party due to the alteration of the DNA 
binding site since R133 is completely conserved between MBD family members while 
mutation of this arginine to an alanine in MBD1 abolishes binding to mCpG (Ohki et al. 
1999).   Another common mutation, T158M, found in the loop structure of the MBD, 
showed only  a 2-fold reduction in the binding to methylated  DNA while it retained 
partial affinity for heterochromatin (Kudo et al. 2001).   Disruption of mCpG binding 
and the ability of MeCP2 to interact with HDACs will affect the role of MeCP2 in 
transcriptional repression.    The brain has the highest abundance of MeCP2 compared to 
any  other  tissue  (Nan  et  al.  1997)  which  might  suggest  that  brain  tissue  is  highly 
susceptible  to  abnormalities  arising  from  aberrant  gene  expression.    This  idea  is 
supported by work carried out in 2000 by Cheadle et al. who noted that patients with   33 
missense mutations had significantly milder disease compared to those with truncated 
isoforms.  This may be due to truncation abolishing MeCP2’s ability to interact with 
Sin3A and recruit histone deacetylase to repress transcription through its TRD (Jones et 
al, 1998, Nan et al, 1998).  However, since inhibition of histone deacetylase activity by 
the drug Trichostatin A only partially relieves transcriptional repression by the TRD 
suggesting the TRD can mediate repression in a histone deacetylase independent manor 
(Jones et al, 1998, Nan et al, 1998).  This may not be the only mechanism.  
 
1.5.2 Disease associated with other MBD proteins 
MBD1, 2, 3 do not have any known disease/syndrome associated with mutations in their 
genes.  Knockout mice have been produced for all except MBD3 for which knockout is a 
lethal genotype.   MBD1 knockout mice show no obvious development abnormalities 
and appeared healthy throughout their life.  However, their neural stem cells exhibited 
reduced  neuronal  differentiation,  increased  genomic  instability  and  deficits  in  adult 
neurogenesis and hippocampal function (Zhao et al, 2003) indicating that MBD1 maybe 
important for normal brain function.  As a consequence of knocking out MBD2,  
MBD2
-/- mice appear to suffer post natal depression but no other physical or mental 
abnormalities (Hendrich et al. 2001).  MBD4 knockout mice suffer increased (3-fold) C 
to G mutations particularly at mCpG sites and when crossed with the Apc
Min/+ mouse the 
resultant  Mbd4
/ ,  Apc
Min/+  litter  have
  increased  levels  of  intestinal  neoplasia  when 
compared to Apc
Min/+ (Miller et al. 2002).   
 
While there are no disease syndromes attached to the MBD1-3 proteins, MBD4 has been 
shown  to  be  mutated  in  colorectal  tumours  (Bader  et  al.  1999)  and  primary  gastric 
cancer (Yamada et al. 2002).  However, expression levels of these proteins have been 
shown  to  vary  in  cancer  cell  lines  and  tissue.    Patra  et  al.  (2003)  compared  the 
expression of MBD1, MBD2 and MECP2 in prostrate and BPH cancer cell lines.  They 
found protein expression levels of MBD1 increased in the cancer cells compared with a 
BPH (human prostatic epithelial) cell line, with the protein levels of MBD2 & MeCP2 
being  repressed  at  the  translation  step,  while  levels  of  DNMT1  and  HDAC1  where 
significantly  increased.  MBD1  has  been  shown  to  repress  transcription  of  the  p16 
tumour suppressor gene (Hendrich et al. 1999) although levels of this protein where not 
analysed.  
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1.5.3 Disease associated with Hypermethylation 
Hypermethylation of CpG islands occurs within the promoter regions of many critical 
cancer genes (Baylin et al. 1999, Esteller et al. 2001, Billard et al. 2002) which leads to 
transcriptional repression.  The promoter region of the π-class glutathione S-transferase 
gene, GSTP1, has been shown to be hypermethylated in >90% of prostate cancers (Lee 
et al. 1997, Lin et al. 2001.), >70% in liver cancers (Tchou et al. 2000) and >30% in 
breast  cancer  (Esteller  et  al.  1998).    The  reduction  in  gene  transcription  has  been 
attributed the hypermethylation event as treatment of the cells with inhibitors of DNMT1 
increased both GSTP1 mRNA and protein levels (Lin et al. 2001, Singal et al. 2001).  
Using siRNA techniques Lin & Nelson (2003) knocked down the transcription of MBD2 
(~79%),  DNMT1  (~83%)  &  MeCP2  (~77%)  in  MCF-7  (breast  cancer)  cells  and 
recorded  an  increase  in  transcription  of  GSPT1  from  only  the  MBD2  and  DNMT1 
siRNA  treated  cells.    DNMT1  and  MBD2  have  also  been  detected  bound  to  the 
hypermethylated GSTP1 promoter in MCF-7 cells using ChIP assays (Lin & Nelson, 
2003) but it is unknown if DNMT1 is repressing transcription although the recruitment 
of DNMT1 to the GSTP1 promoter is dependent on the methylation of the CpG island 
(Lin & Nelson, 2003).  These data suggest that both MBD2 and DNMT1 are involved in 
aberrant transcriptional repression of GSTP1 in the MCF-7 cell line although the exact 
role of DNMT1 has not been described at this time.   
 
MBD2 expression has been studied in other cell lines.  Billard et al. (2002) studied 
MBD2  expression  during  normal  and  pathological  growth  of  the  human  mammary 
gland.  They found that MBD2 expression was 20-30 fold higher in benign tumours than 
normal tissue, but in neoplastic samples MBD2 and MECP2 were deregulated.  It was 
also noted that MBD2 expression varied with tumour size in invasive ductal carcinomas.  
In  contrast  to  the  varied  transcription  in  breast  cancer,  human  colorectal,  gastric 
cancerous tissues (Kanai et al. 1999) and the peripheral blood lymphocytes in bladder 
cancer patients (Zhu et al. 2004) show a decrease in transcription suggesting there could 
be a protective role for MBD2 in these diseases. 
 
DNMT1  has  also  been  shown  to  be  over  expressed  in  various  cancers  compared  to 
normal  tissue  (Sun  et  al.  1997,  Kanai  et  al.  2001,  Saito  et  al.  2001), and  that  over 
expression correlated
 significantly with detection of methylated CpG islands (Kanai et 
al. 2001).  However, DNMT1 is expressed mainly during S-phase and because tumour 
tissue
 is presumed to contain a greater proportion of dividing cells
 than normal tissue is,   35 
the increase in DNMT1 expression could be due to an increase in dividing cells or an 
increase in each cell. 
 
MBD2 and DNMT1 have been implicated as key players in various gastric cancers and 
are therefore targets for anticancer drugs.  MBD2 appears to be the more attractive target 
as knocking out MBD2 does not appear to have any distinct or severe side effects unless 
you are a nursing mouse, and while inhibition of DNMT1 can restore almost wild type 
growth in cell culture it is not without side effects.  The interaction between p66 and 
MBD2 within the MeCP1 complex is an obvious target for drug design.      
 
1.6 Non-methylated CpG and CXXC domains 
The CXXC domain is characterized by a cystine rich CXXCXXC repeat where X is any 
amino acid.  CXXC domains are found in chromatin binding proteins MBD1 (2 or 3 
CXXC  domains  depending  on  splice  variant),  DNA  methyltransferase  1  (DNMT1) 
(Bestor  1992),  CpG-binding  protein  (CGBP)  (Lee  et  al.  2001)  and  the  mixed-linage 
leukaemia gene (MLL) (Tkachuk et al, 1992).  The CXXC domain in DNMT1 as been 
shown to bind zinc (Bestor 1992) while the CXXC domain of CGBP has been shown 
require zinc to bind non-methylated CpGs in vitro (Lee et al. 2001).  The 3
rd CXXC 
domain in MBD1 has also been shown to bind non-methylated CpG motifs and cause the 
repression of non-methylated reporter genes via the transcriptional repression domain 
while CXXC1 & -2 do not (Jorgensen et al. 2004).  The CXXC domains (1 to 3) from 
MBD1, HRX/MLL, CGBP and DNMT1 show  sequence similarity mainly through 8 
cystine residues that form the two zinc clusters (fig 1.7) with CXXC-3 showing further 
homology to CGBP and other non-methylated DNA binding proteins (Jorgensen et al. 
2004).  The CXXC domain sequences shown in figure 1.7 also contain a glycine residue 
succeeding  the  first  cysteine  in  each  cluster  (pink)    However,  MBD1  CXXC1  and 
CXXC2 lack the  sequence KFGG (and other conserved residues D 31 & Q43) compared 
to the other CXXC domains.   
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Figure 1.7  Alignment of CXXC domains from hMLL (NP_005924), hDNMT1 
(NP_001370.1), hCGBP NP_055408), MBD1 CXXC1, CXXC2, CXXC3 (NP_056671).  
Sequences were aligned using Jalview (Clamp et al, 2004).  Cysteines involved in forming the 
zinc clusters are shaded blue and numbered according to the cluster they participate in.  
Residues conserved between domains than bind non-methylated CpG are shaded green and non 
cysteine common residues between all sequences are coloured pink 
 
As noted above (p6) methylation occurs at 70-80% of mammalian CpG sites (Ehrlich 
and Wang 1981) with the remaining unmethylated CpG sites being found in CpG rich 
islands usually found in the promoter regions of house keeping genes (Bird 1986). It is 
therefore likely that CXXC domains have a role in binding to CpG islands.  Recently 
Thomson et al (2010) showed that CXXC finger protein 1 (CFP1), part of the Setd1 
H3K4 methyltransferase complex (Lee et al, 2007), localize to CpG islands and appears 
to be required for H3K4 methylation, which is normally associated with transcriptionally 
active  promoters.    In  acute  myeloid  leukemia  the  MLL  protein  is  fused  with  LCX 
(leukemia-associated  protein  with
  a  CXXC  domain)  (Ono  et  al,  2002).    This  fusion 
protein is essential for target recognition, transactivation, and myeloid transformation by 
the MLL oncoprotein (Atton et al, 2004).  With a mutated CXXC domain from MLL 
which is unable to bind non-methylated CpG, the MLL/LCX fusion protein is unable to 
induce transcription from target genes.  The direct functions of the CXXC domains from 
MBD1 are currently unknown.  It has been shown that the CXXC domain from DNMT1 
is essential for enzymatic activity and that single point mutations in the CXXC domain 
disrupt  the  DNA  binding  ability  but  do  not  interfere  with  DNMT1  targeting  to 
replication foci (Fatemi et al, 2001., Pradhan et al, 2008).  CXXC domains also have 
been shown to interact with various proteins involved in chromatin remodeling.  Xia et 
al (2003) investigated the protein-protein interactions of the MLL/LCX CXXC domain. 
Using GST-pull down assays and co-immunoprecipitation they were able to show that 
the CXXC domain interacts with CtBP (C-terminal binding protein) and hPc2 (human 
polycomb 2 protein).  CtBP can meditate transcriptional repression by recruiting HDACs 
(Subramanian  & Chinnadurai, 2003) while hPc2 is a member of the PRC1 complex 
(shao  et  al,  1999).    MLL/LCX  CXXC  recruitment  of  PRC1  mediates  transcription   37 
repression independent  of HDAC activity (Xia  et al, 2003).  Fuks  et al (2000) also 
reported the DNMT1 CXXC domain could mediate HDAC-independent transcriptional 
repression using the Gal4 reporter system.  The MBD1 CXXC3 domain is similar to the 
MLL & DNMT1 CXXC domain in sequence and it can bind non-methyl CpG DNA 
(Jorgensen et al. 2004).  With this similarity in mind, Sakamoto et al (2007) used a yeast 
two hybrid screen to identify proteins that interact with the three CXXC domains from 
MBD1.  They were able to show the MBD1 CXXC3 also interacted with hPc2 while 
CXXC12 interacted with amino acids 250-337 of Ring1b.  Ring1b, like hPc2, is a major 
component of the Polycomb group (PcG) multiprotein PRC1 complex (Min et al, 2003).  
This suggests that although the first two CXXC domains from MBD1 do not bind CpG 
DNA they have a role in transcriptional repression through the interaction of the PRC1 
complex.   
 
The solution structure of the MLL CXXC domain (Allen et al, 2006), MLL in complex 
with DNA (Cierpicki et al, 2009), xDNMT1 (Thomson & Smith, unpublished) and the 
crystal structure of DNMT1 CXXC in complex with DNA (Song et al, 2010) have been 
solved.  The structure of MLL CXXC domain forms a crescent like structure containing 
two zinc atoms.  Each zinc atom is coordinated by 4 cystine residues (figure 1.8).  These 
two zinc atoms are required for structural integrity of the domain since mutation of any 
of the conserved  cysteine residues  results in an unfolded protein (Allen et al, 2006, 
Cierpicki et al, 2009)     
 
Figure 1.8 Stereo view of the solution structure of the MLL CXXC domain in cartoon 
form (Cierpicki et al, 2009).  Zinc atoms shown as gray spheres, N, N-terminus; C, C-
terminus.  PDB 2KKF (Figure prepared using PyMol). 
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Shown in figure 1.9, the MLL CXXC domain binds the CpG motif in the major groove 
though formation of hydrogen bonds from the N4-amine groups of C118 and C106 and 
the backbone oxygen of K1185 and K1186 respectively.  The side chain of K1186 forms 
hydrogen bonds to G119 while the side chain amide of Q1187 hydrogen bonds to G107 
(Cierpicki et al, 2009).   Cierpicki et al (2009) also discovered weak NOEs between the 
side chains of R1150, S1152 and L1197 and the minor groove.  Mutation of R1150 and 
L1197  to  alanine  resulted  in  a  5  and  4  fold  reduction  in  DNA  binding  affinity 
respectively.   
 
 
 
Figure 1.9 Stereo view of the solution structure of the MLL CXXC domain in complex 
with DNA in cartoon form showing the CpG palindrome in red, the DNA backbone in 
orange and the residues involved in DNA binding N, N-terminus; C, C-terminus. PDB 
2KKF (Cierpicki et al, 2009) (Figure prepared using PyMol). 
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CHAPTER TWO 
 
INTRODUCTION PART 2: PROTEIN NMR 
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m – magnetic quantum number 
2.1 Nuclear Magnetic resonance 
In  this  section  the  fundamental  theory  underlying  the  experiments  that  I  applied  in 
investigating MBD1 CXXC1 and MBD1 CXXC12 are outlined.  I have written this 
chapter from the point of view of a biologist using NMR as a technique used to answer 
questions  about  a  proteins  function.    As  such  I  hope  that  a  scientist  without  any 
experience of NMR should be able to follow and understand. 
 
2.1.1 Basic Theory of one dimensional NMR 
Nuclear magnetic resonance (NMR), first described by Felix Bloch and Edward Mills 
Purcell in 1946, is the phenomenon of atoms absorbing radio-frequency electromagnetic 
radiation (RF) under the influence of a magnetic field.  For protein NMR the detection of 
this absorption requires the use of isotopes of carbon, nitrogen and hydrogen which have 
a spin 1/2.  Spin is a quantum mechanical property attributed to protons, neutrons and 
electrons, measured in multiples of ½ and can be positive or negative.  In protein NMR, 
isotopes of carbon, nitrogen and hydrogen that have a nuclear net spin +/- ½.  Nuclear 
net spin ½ occurs when the isotopes have an unpaired proton e.g. 
1H, 
13C, 
15N are used.  
It is a quantum mechanical requirement that nuclei with a spin ½ be in one of two states 
(low  or  high  energy  state)  when  placed  in  a  magnetic  field  (figure  2.1).    When  no 
external magnetic field is applied the two states are of equal energy.  The energies of the 
spin states are split with the application of a magnetic field.  
 
 
 
Figure 2.1  Figure showing the effect on the potential energy of the spin states on a 
nucleus when an external magnetic field is applied.    
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 At  equilibrium  jumping  from  one  spin  state  to  the  other  is  a  relatively  infrequent 
occurrence.  However, application of RF energy equal to the difference between the two 
states will generate a greater amount of jumping between states. The frequency of the 
RF energy required for nuclei to absorb radiation is known as the Larmor frequency.  
The Larmor frequency is equal to the frequency of the precessional orbit of the nucleus 
in the applied magnetic field.  After a pulse of RF energy, the spin states of the majority 
of nuclei will under go relaxation to their original state.  This relaxation is known as a 
Free  Induction  Decay  (FID)  The  energy  required  to  flip  the  states  depends  on  the 
strength of the magnetic field they are placed in, the type of nucleus e.g. 
1H or 
13C, and 
the  chemical  environment  of  the  nucleus  e.g.  the  methyl  and  hydroxyl  protons  of 
methanol absorb at different frequencies and the amide protons of two tryptophans in a 
protein  are  likely  to  absorb  at  different  frequencies  because  they  are  in  different 
chemical environments.  This effect is known as chemical shift and is a major source of 
information in NMR spectra for assignment of atom types since protons attached to Cα, 
amide N and side chain heavy atoms have characteristic chemical shifts.  
 
2.2 Homonuclear 
1H NMR 
 In  protein  NMR  there  are  various  experiments  that  can  be  performed  in  order  to 
elucidate a three dimensional structure.  In essence they fall into 2 categories: through 
bond, where the magnetization is transferred from atom to atom through the intervening 
covalent  bonds;  and  through  space,  where  the  magnetization  is  transferred  between 
atoms that are close together (< 5Å apart) but not necessarily covalently linked.  The 
experiments  are  performed  on  samples  that  are  either  unlabeled  or  labeled  with 
13C 
and/or 
15N.  NMR structures of small proteins <10kDa can normally be elucidated with 
unlabelled samples using homonuclear NMR, since naturally abundant hydrogen has a 
spin ½ (Wuthrich, 1986). 
 
2.1.1 Water suppression 
The NMR experiments carried out for this thesis were performed in aqueous solutions. 
The concentration of 
1H nuclei in water is approximately 110 M compared to 0.5-1.0 
mM for the protein molecules.  This results in ~10
5 greater equilibrium magnetization of 
water 
1H spins.  Without suppressing the signal from the water, detection of the protein 
signal  without  spectrum  distortions  is  impossible.    By  replacing  H2O  with  D20 
(99.999%) as the solvent, it is possible to reduce the H2O resonance signal a factor of 
10
5.  However, signals from exchangeable, e.g. amide 
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absent  from  the  spectra.    Since  scalar  coupling  and  dipolar  interactions  between 
backbone amide 
1HN spins with amide 
15N and 
1Hα spins are required for backbone 
assignment certain NMR experiments must be carried out in an H2O solvent. 
The simplest method of water suppression is presaturation.  A long low powered pulse 
which is applied scrambles the water signal around the applied Z-axis.  The net effect of 
this pulse causes the water signals from different parts of the sample to cancel each other 
out  before  the  main  sample  pulse  sequence  is  initiated.    Water  suppression  by 
presaturation is a simple and effective method. However, 
1H
α spins close to the water 
signal can be saturated by the RF field and saturation transfer may partially saturate 
exchangeable 
1H spins.   A more effective water suppression technique is excitation 
sculpting (Hwang and Shaka, 1995).  This method of  water suppression is executed 
before detection of the FID and requires pulse field gradients.  A gradient pulse is first 
applied to scramble the homogeneity of magnetization in the sample.  A selective 180º 
pulsed on water followed by a non selective 180º pulse turns the water through 360º.  
Since  the  initial  magnetization  on  non-water  protons  has  been  turned  though  180º  a 
second gradient pulse refocuses the non-water signals but not the water.  A variation of 
this excitation sculpting is known as a 3-9-19 watergate.  This type of water suppression 
is more suited to 2D and 3D experiments due to the use of selective pulses that do not 
excite water rather than the water selective and non-selective pulse in the Hwang and 
Shaka (1995) method.  The use of the non-water selective pulses shortens the time of the 
water suppression element in the pulse sequence, reducing the length of time the sample 
has to relax.    
 
2.2.2 1D homonuclear NMR 
A 1D 
1H NMR experiment consists of two parts: preparation and acquisition.  In the 
simplest case, shown in figure 2.2, preparation is a 90˚ pulse applied along the x-axis 
which  transfers  the  magnetization  from  the  z-axis  into  the  transverse  plane  to  the 
negative  y-axis.    The  receiver  coil  records  the  signal  emitted  by  the  nuclei  as  they 
precess at their Larmor frequency (figure 2.3)     
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Figure 2.2  Schematic diagram of a simple 1D NMR experiment  
 
 
 
 
 
 
 
 
 
Figure 2.3  Effect of applying an external RF field (red) of sufficient strength along 
the x axis to induce rotation of the equilibrium magnetization (green) magnetization into 
the transverse plane to –y (dark blue). 
 
The 1D 
1H  NMR experiment records the RF emission from the nuclei of 
1H atoms only 
and the FID, a concentration of sinusoidal waves (time domain) is Fourier transformed 
to provide a frequency domain spectrum  (figure 2.4).    
 
Figure 2.4  Fourier transformation of a time domain signal to a frequency domain 
spectrum 
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This 1D spectrum can be used to provide information as to whether the protein is 
structured.  The x-axis represents the chemical shift, a relative frequency scale expressed 
in parts per million compared to the reference compound tetramethylsilane and figure 
2.5 relates the peaks to different chemical environments. 
 
 
Figure 2.5  1D 
1H  spectra  of  unlabelled  hMBD1  CXXC1  (10mM  deuterated 
tris(hydroxymethyl) aminomethane, 250mM NaCl, pH 6.5)  relating chemical shift (in 
ppm) to different chemical environment. 
 
The  1D 
1H  experiment  can  be  a  powerful  diagnostic  tool  since  the  sharpness  or 
broadness of the peaks relate to how structured the protein/peptide is. Very sharp methyl 
peaks coupled with lack of dispersion (where peaks cannot be distinguished one from 
another) of the backbone amides clustered around 7-8.5ppm can indicate unstructured 
protein.  A structured protein will show good dispersion of peaks (Figure 2.5) in the 
methyl  and  backbone  amide  regions.    Broader  than  expected  line  widths  can  be 
indicative of protein aggregation and/or conformational flexibility. 
 
2.2.3 2D Homonuclear 1H NMR 
The 1D 
1H experiment is limited in the information it can provide and it is not usually 
possible to assign individual peaks to specific amino acid residues due to overlap.  2D 
homonuclear NMR experiments utilize magnetization transfer between hydrogen nuclei 
that appear as crosspeaks in the spectra.  This correlation of hydrogen nuclei is the basis 
of  amino  acid  assignment  and  distance  restraint  measurement.    The  simplest  2D 
homonuclear experiment (COSY - Correlation Spectroscopy) takes the preparation and 
Backbone H
N 
aromatic  Hα 
Side-chain H
N 
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detection from a 1D experiment (figure 2.2) and adds an indirect evolution time (T1) and 
mixing sequence (figure 2.6).    
 
 
 
Figure 2.6  Anatomy of a simple 2D homonuclear experiment (COSY). 
 
After preparation, the spins precess for a given time, T1, where the magnetization is 
labelled  with  the  chemical  shift  of  a  proton.    The  mixing  time  transfers  some  of 
magnetization to another proton before detection.  During detection, the magnetization is 
labelled  with  the  chemical  shift  of  the  correlated  proton.    Magnetization  can  be 
transferred during the mixing time by scalar coupling for through bond Total Correlation 
Spectroscopy/Correlation  Spectroscopy  (TOCSY/COSY)  or  dipolar  interactions  for 
through  space  Nuclear  Overhauser  Effect  Spectroscopy  (NOESY)  experiments.    The 
COSY  experiment  only  transfers  magnetization  through  up  to  3  bonds  due  to  the 
weakness of the scalar coupling over greater number of bonds.  Figure 2.7 illustrates the 
connectivities  that  give  rise  to  cross  peaks  in  TOCSY  &  NOESY  spectra.    A  2D 
homonuclear experiment produces a spectrum with two frequency axes.  Signals for 
each  proton  detected  are  recorded  along  a  diagonal,  splitting  the  spectrum  into  two 
halves.   
 
 
 
 
Figure 2.7  Connectivities that can give rise to cross peaks in A) 
1H-TOCSY and B) 
1H-NOESY.  Solid arrows represent intra-residuer transfer, dotted lines represent inter-
residue transfer. 
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Figure 2.8  Schematic of a 2D homonuclear spectrum.  Protons A & B are correlated 
by the cross peaks X.  Cross peaks either side of the diagonal result from magnetization 
originating  from  each  proton.  The  green  arrow  indicates  a  cross  peak  arising  from 
magnetization which originated on proton A that was transferred to B. 
 
This  diagonal  results  from  magnetization  which  has  not  been  transferred  during  the 
mixing time and therefore remains on the same nucleus.  Signals not on the diagonal are 
the result of two protons exchanging magnetization during the mixing time (figure 2.8).      
The  cross  peaks  that  correlate  a  proton  to  another  proton  provide  information  for 
assignment of each cross peak in the spectrum.   
 
2.3 Protein Assignment using 
1H homonuclear data 
There  are  typically  three  2D  homonuclear  experiments,  COSY  (Correlation 
Spectroscopy),  TOCSY  (Total  Corralation  Spectroscopy)  and  NOESY  (Nuclear 
Overhouser  Effect  Spectroscopy)  that  can  be  used  for  resonance  assignment  and 
extraction of distance information.  These experiments are used to assign spin systems, 
each of which is a group of resonances representing the chemical shifts of each residues 
protons (amide, alpha and side chain).  As with the 1D 
1H spectrum (figure 2.5) specific 
regions within the 2D 
1H spectrum correlate transfer between different proton groups.  
Figure 2.9 shows the layout of a 2D 
1H spectrum relating chemical shift coordinates to 
proton-proton magnetization transfer. 
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Figure 2.9 Layout of magnetization transfer for a 2D 
1H experiment in H2O 
 
2.3.1 Correlation spectroscopy 
The COSY experiment transfers the magnetization by scalar couplings and as such only 
crosspeaks between protons that are up to 3 bonds apart in the spectrum since couplings 
over  3  bonds  are  too  small  to  be  visible.    The  COSY  experiment  is  important  for 
discriminating β & γ protons for example in glutamate where the chemical shift ranges 
of the β & γ protons overlap.  There would be a COSY cross peak correlating the Hα to 
the Hβ but not to the Hγ. Every amino acid has specific chemical shift ranges for protons 
with in each residue.    
The TOCSY (total correlation spectroscopy) experiment correlates every proton in an 
amino acid residue (figure 2.10) Magnetization is transferred through the entire spin 
system (amino acid) by successive scalar couplings.  As both the TOCSY and COSY 
experiments depend on scalar coupling, they can be used for identifying the chemical 
shift values for the resonances within each spin system.     
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Figure 2.10  Diagram  the  pattern  of  crosspeaks  for  an  arbitrary  spin  system  in  a 
TOCSY experiment.  Green circles – autocorrelation crosspeaks for the nuclei of the 
spin system, blue circles – cross peaks correlating nuclei.   
 
However, this characteristic pattern (figure 2.11) is shared between certain amino acids 
e.g. cysteine, aspartic acid, phenylalanine, histidine, asparagine, tryptophan and tyrosine 
have the same pattern.  Therefore while it is possible to assign cross peaks to a particular 
spin system it is not possible to assign the spin system to a specific amino acid on the 
basis of the pattern of chemical shifts alone. It is not possible to sequentially link or 
calculate structure based solely on spin system assignments in COSY/TOCSY spectra.  
Assignment of spin systems to sequence specific amino acids requires the spin systems 
to be linked together (see chapter 2.3.3). 
δ
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Figure  2.11  Characteristic  COSY  spectra  for  each  of  the  10  classes  of  amino  acid 
residiues and aromatic side chains (reproduced from Smith, 1994)   
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2.3.2 Nuclear Overhauser Effect Spectroscopy  
For structure determination by proton NMR, information about the distance between 
atoms is crucial.  The NOESY (Nuclear Overhauser Effect Spectroscopy) experiment 
relies on dipolar interactions of spins to transfer the magnetization, through space, from 
one  nucleus  to  another.    This  through  space  magnetization  transfer  allows  distance 
information to be obtained for both intra- and inter-residue interactions between protons 
that are typically less than 5Å apart.  The strength of correlation between two nuclei 
depends on the distance between them.  The closer the nuclei are to each other the more 
intense the cross peak in the spectrum.  The NOESY spectrum not only contains cross 
peaks for intra-residue correlation, which are at the same chemical shift coordinates as 
the COSY/TOCSY correlations, but also inter-residue correlations between nuclei close 
in space.  This information is required for linking spin systems together in order to 
assign them sequence specifically. 
   
2.3.3 Sequential Assignment 
Since correlations between nuclei in the same spin system are at the same chemical shift 
in both NOESY and TOSCY/COSY spectra and the Hα to HN i+1 distance is often short 
there is typically an NOE cross peak correlating the Hα from one amino acid and the HN  
the next in sequence.  Figure 2.12 shows an example of backbone sequential linking 
using the Hαi to HN i+1 inter-residue NOE.  It is not possible to rely solely on the Hαi to 
HN i+1 crosspeaks to sequentially link spin systems since there is not always a strong or 
well resolved  Hαi to HN i+1  cross peak.  For example, residues in an alpha helix have 
weak Hαi to HN i+1 but strong HN to HN i+1 NOEs.  Using the known protein sequence it is 
possible to link spin systems using NOE crosspeaks correlating HN and Hβ protons and 
HN and HN resonances of i to i+1 to make the sequential assignment less ambiguous.  
Another problem arises when trying to sequentially link a proline residue since proline 
lacks an amide proton.  Proline residues can normally be sequentially linked using the 
correlation of the proline Hδ and the Hα of the residue before.  Once spin systems have 
been linked sequentially, assignment of the side chain chemical shifts can be completed 
using the COSY experiment to help distinguish side chain protons. 
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Figure 2.12  Example of sequentially linking backbone resonances of hMBD1 CXXC1 
using  2D  homonuclear  TOCSY  (green)  &  NOESY  (blue)  spectra  by  identifying  the 
inter-residue 213Arg Hα to 214Arg HN crosspeak. 
 
2.3 Heteronuclear NMR  
Atom  specific  assignment  of  resonances  observed  in  homonuclear  experiments  are 
dependant on well resolved spectra.  This can normally be carried out for small globular 
proteins that produce spectra with well dispersed chemical shifts for the protons in each 
of the residues.  Spectra become less well resolved as proteins increase in size due to:  
1)  The  increase  in  number  of  resonances  due  to  the  increase  in  number  of  protein 
residues while the chemical shift range over which signals are spread does not change.  
This  increases  the  probability  of  overlap  of  cross  peaks  making  assignments  more 
difficult. 
 2) The decreased rotational correlation time of the protein causing faster relaxation, thus 
increasing overlap due to from broader linewidths.   
The use of 
15N labelled protein allows NMR experiments to be carried out which add a 
third (nitrogen) dimension to the spectra.  Separation overlapped 2D crosspeaks possible 
because the spin systems can have different nitrogen chemical shifts (see chapter 4 p81 
for  a  specific  example).    When  proteins  are  labelled  with  both 
13C  and 
15N,  NMR 
experiments  can  be  recorded  that  transfer  magnetization  across  the  peptide  bond 
connecting two spin systems though bonds meaning you don’t have to use NOEs to get 
sequential assignment to work.         
1H (PPM) 
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2.3.1 2D 
15N-HSQC 
The 
15N  heteronuclear  single  quantum  correlation  (HSQC)  experiment  correlates  the 
nitrogen atom of an NH(x) group to the attached proton.  Thus, the HSQC spectrum 
contains a cross peak for each backbone amide group except proline.  Also visible in an 
HSQC spectrum are the NH2 side chain groups of Asn & Gln, the aromatic NH groups 
of Trp & and more rarely His and the NƐHƐ of Arg (figure 2.13).  
The pulse sequence for a basic HSQC experiment is illustrated in figure 2.14.  The 
INEPT (Insensitive Nuclei Enhanced by Polarization Transfer) pulse sequence is used to 
transfer magnetization from the proton to the nitrogen atom.  A 180º pulse mid evolution 
inverts the proton scalar coupling so that F1 (nitrogen dimension) lineshape does not 
contain contributions from 
1H scalar coupling.  A reverse INEPT sequence transfers the 
magnetization back to the proton and detection occurs.  Decoupling the nitrogen channel 
removes the contribution of the nitrogen scalar coupling to the F2 line shape. There is no 
diagonal in the HSQC spectrum because different nuclei are observed during T1 and T2 
 
 
 
 
 
 
δ 
1H  (ppm) 
δ 
15N  
(ppm) 
Figure 2.13 
15N HSQC of hMBD1 CXXC1, (Bruker Avance 800 MHz 
with cryoprobe, 10mM deuterated tris(hydroxymethyl)aminomethane,, 
250mM NaCl, pH 7.5, 293K).                                                                                                                                                  53 
 
 
Figure 2.14  Pulse sequence for a basic HSQC experiment.  Thin bars are 90º & thick 
bars are 180º pulses.  Pulses are applied with x-phases unless indicated above the bar 
 
Although it is not possible to assign cross peaks to specific residues using an HSQC 
alone, the spectrum provides a unique footprint for each protein.  This footprint can 
change depending on buffer conditions and binding to ligands.  This is due to a change 
in the nuclear shielding that the atoms are experiencing, which affects the chemical shift 
at which their resonances are observed at.  This is a useful technique for investigating 
which residues, if assignments are available, interact with an added compound.  Another 
important technique that requires use of the HSQC experiment is hydrogen-deuterium 
exchange for investigating solvent accessibility and hydrogen bonding.  In solution, the 
amide hydrogen in the peptide bonds exchange with the solvent.  When D2O is used as a 
solvent in place of H2O, the amide hydrogen exchange with deuterons.   Since deuterons 
cannot  be  detected  in  a 
15N  HSQC  experiment  those  cross  peaks  that  survive  are 
considered to originate from slowly exchanging HN which result from amide protons 
either involved in hydrogen bonds, or burred within a hydrophobic core. 
 
2.3.2  3D 
15N heteronuclear NMR experiments 
Ambiguity  of  sequential  resonance  assignment  in  overlapped  2D  spectra  can  be 
generally overcome using 3D heteronuclear versions of 2D homonuclear experiments.  
These experiments combine a 2D homonuclear TOCSY or NOESY pulse sequence and 
an  HSQC  pulse  sequence.    For  an  HSQC-NOESY  experiment  the  pulse  sequence 
(Figure  2.15)  starts  with  a  homonuclear  NOESY  with  a  90º  pulse  to  switch 
magnetization to the transverse plane, a variable evolution time t1 to provide chemical 
shift information in the F1 domain then another 90º pulse to move the magnetization 
back  to  the  z-axis  with  magnetization  transfer  through  dipolar  coupling  during  the 
mixing  time  Tm.    The  remainder  of  the  pulse  sequence  is  identical  to  the  HSQC 
experiment described above.                                                                                                                                                      54 
 
 
 
Figure 2.15  Pulse sequence for a 3D 
1H-
15N HSQC-NOESY experiment. Thin bars 
are 90º & thick bars are 180º pulses.  Pulses are applied with x-phases unless indicated 
above the bar.  
 
The advantage of introducing the 3
rd dimension in a 
15N HSQC-NOESY or –TOCSY 
experiment  is  that  since  only  cross  peaks  linked  to  an  NH  are  seen  in  each  slice, 
overlapped peaks can normally be separated by their 
15N chemical shift (figure 2.16). 
 
 
Figure 2.16  Illustration showing the relationship between a 2D homonuclear spectrum 
and  a  3D  heteronuclear  spectrum.    The  overlapped  cross  peaks  in  the  2D  spectrum 
(green) are separated by the introduction of the nitrogen dimension (F3).   
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2.4 Data Processing 
Before resonance assignment can begin, the recorded NMR data has to be processed 
from  the  time  domain  to  the  frequency  domain.    Normally  the  direct  Fourier 
transformation (DFT) of the recorded NMR signal does not yield an optimal spectrum.  
In order to maximize the information that can be extracted from the spectrum a number 
of  digital  signal  processing  techniques  can  be  applied  before  and  after  Fourier 
transformation.   
 
2.4.1 Pre-Fourier transformation data processing 
A DFT of the FID recorded by the NMR spectrometer produces a frequency domain 
signal with a Lorentzian line shape.  The shape of the line can be improved to give 
greater resolution and sensitivity by applying functions to the FID before DFT. The 
Lorentzian line shape is produced from an FID that decays exponentially.  Therefore, if 
the decay of the FID is altered to decay with a different time dependence the resolution 
and/or single to noise can be adjusted.  Multiplying the FID by exponential function will 
deemphasize the later parts of the FID where the signal from the protein is weakest.  The 
Lorentzian-to-Gaussian is a common function applied to the FID.  The Lorentzian lines 
are converted to Gaussian lines by multiplying by an increasing exponential followed by 
a Gaussian function.  Figure 2.17 shows the effect of applying the Gaussian function to 
the FID. 
 
     
 
Figure 2.17  Diagram  of  the  effect  on  line  shape  for  a  Lorentzian-to-Gaussion 
transformation.  Line width at half height are the same. (Adapted from James Keeler 
lecture  notes  University  of  Cambridge,  http://www-
keeler.ch.cam.ac.uk/lectures/understanding/chapter_4.pdf) 
 
Lorentzian 
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A function similar to the Gaussian is the sine bell function.  There is also a squared sine 
bell function which is more concentrated around the maximum.  Figure 2.18A illustrates 
the difference between sine bell and squared sine bell and figure 2.18B illustrates the 
flexibility of the (squared) sine bell function.  The squared sine bell function is good to 
use because it goes smoothly to zero which produces fewer truncation artifacts compared 
to the sine bell function. 
 
 
Figure 2.18   comparison of sine bell & squared sine bell curves (A) Flexibility of the 
squared sine bell function by applying a phase shift (B).  (Adapted from James Keeler 
lecture  notes,  University  of  Cambridge,  http://www-
keeler.ch.cam.ac.uk/lectures/understanding/chapter_4.pdf) 
 
 For each NMR experiment a sweep width is set which is the range over which the data 
is collected (set in ppm or Hz).  To obtain a high digital resolution it is necessary to 
record a large number of data points in this sweep width (Hz/data points).  The noise in 
an FID remains more or less constant whereas the signal sinusoids decay over time.  
Therefore, at some point noise contributes more to the FID than the nuclear resonances.  
It is possible to record  a smaller number of points and then extrapolate the FID by 
process called zero-filling if the signal has decayed by the end point.  Zero-filling simply 
adds zeros to the data sequence.  If the signal has not decayed when recording stops the 
FID is truncated and zero-filling leads to oscillations around the base of the peak called 
sinc-wiggles (the name comes from the peak shape as it is related to a sinc function). 
(figure 2.19).                                                                                                                                                  57 
These sinc-wiggles can cause problems during resonance assignment later on.   
 
 
 
 
 
Figure 2.19  Figure  illustrating  the  effects  of  truncation  of  the  FID  on  the 
corresponding spectrum.  For spectrum A the FID was allowed to decay to almost zero 
where  as  spectrum  B  shows  sinc  wiggle  artifacts  caused  by  truncation  of  the  FID. 
(Adapted  from  James  Keeler  lecture  notes,  University  of  Cambridge,  http://www-
keeler.ch.cam.ac.uk/lectures/understanding/chapter_4.pdf) 
 
2.4.2 Post-Fourier transformation data processing 
After DFT the spectrum normally displays a phase error.  This is because the time-
domain signal is a complex signal as the sum of sine and cosine functions.  The DFT of 
this  complex  time  domain  results  in  a  frequency  domain  comprising  of  real  part 
(absorption) and an imaginary part (dispersion), shown in figure 2.20, which are out of 
phase. This results in their full width of the peak at half maximum no longer being the 
same for each part. 
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Figure 2.20  illustration showing the real (absorption) and imaginary part (dispersion) 
of a Lorentzian. 
 
 
Applying  zero-order  (frequency  independent)  correction  will  correct  phasing  at  the 
chosen pivot point.  To correct remaining phase errors away from the pivot point, first 
order (frequency dependent) correction is applied.  A curved or rolling baseline makes it 
more difficult to pick peaks in a spectrum and is also a source of error in quantification. 
Baseline distortions are mainly caused by the corruption of the first few data points of an 
FID.  Baseline  correction  methods  fall  into  two  categories,  time  domain  correction 
methods that reconstruct the corrupted data points in the FID and frequency domain 
correction methods that construct baseline curves to fit the spectra directly then subtract 
these  baseline  curves  to  remove  the  distortion.    After  adjusting  the  processing 
parameters to produce a well resolved spectrum, the data can be loaded into various 
programs for resonance assignment and production of NMR distance constraints (See 
chapter 4) 
   
2.5 Alternative to DFT processing 
Processing using Fourier transformation is a fast way of producing a frequency domain 
spectrum  from  a  recorded  FID.    The  DFT,  as  shown  above,  introduces  oscillation 
artifacts when the FID is truncated.  If strong window functions are applied to reduce 
these artifacts there is a reduction in resolution.  In the case of 3D NMR experiments 
where the indirect detected dimensions are truncated due to time constraints, various 
methods  have  been  developed  to  overcome  this  problem.    For  example,  maximum 
entropy reconstruction (Sibisi et al, 1984), linear prediction (Barkhuijsen et al, 1985), 
maximum  likelihood  (Hoffman  et  al,  1989)  and  Multi-Dimensional  Decomposition 
(Orekhov et al, 2003) .  Processing of the 3D data in this thesis was carried out using the 
maximum entropy reconstruction method. The maximum entropy reconstruction method                                                                                                                                                59 
creates a trial frequency domain spectrum then inverse FT back to an FID to compare 
with the FID recorded on the spectrometer.  The software then adjusts the simulated 
frequency domain spectrum until the inverse FT matches the recorded FID.  The inverse 
FT will never exactly match the recorded FID since the simulated frequency domain is 
devoid of noise.  Noise can be introduced to the simulated frequency domain spectrum 
so that the inverse FT will match the recorded FID  more closely.  Using maximum 
entropy  reconstruction  on  truncated  data  will  normally  produce  a  frequency  domain 
spectrum with improved resolution compared to the Fourier transformation spectrum.  
However, maximum entropy reconstruction does not produce spectra that are as resolved 
and distortion free as the Fourier transformation of an untruncated FID.      
 
2.6 important considerations for recording NMR spectra 
Recording  NMR  spectra  is  not  as  simple  as  putting  a  protein  sample  in  a  tube  and 
placing it in the NMR machine.  Various characteristics of the protein have to be taken 
into account in order to prolong the life of the sample enough to record the required data.  
Not only are conditions that suit the protein important but also conditions that result in 
good spectra. 
 
2.6.1 Temperature, pH and Salt 
Protein samples should be kept at the lowest temperature possible in order to prolong the 
life of the sample.  However, low temperatures are generally not suited to recording 
NMR spectra due to slower molecular tumbling, which leads to broader lines and lower 
sensitivity.  However, high temperatures can also increase the rate of exchange with 
water and broaden the line widths due to increased dynamics and will ultimately cause 
the denaturation of the protein.  Therefore a temperature must be chosen to give the best 
overall  compromise  of  resolution  and  sample  life.    Figure  2.21  shows  the  effect  of 
temperature on the xDNMT1 CXXC domain in 5K steps from 283 K to 303K.  As we 
increase temperature, the resolution increases as lines narrow around the 8.75 to 9.5 ppm 
region.  The spectrum at 293K appears to present the best overall compromise conditions 
for adequate resolution.   
The optimum pH for protein NMR is pH 4.0-4.5 since amide proton exchange with 
water  is  slowest  at  this  pH.    As  you  move  away  from  this  range,  amide  exchange 
increases which can result in fewer amide protons being visible.  This can be seen in the 
15N spectra of hMBD1 CXXC1 where NH of histidine 200 is not visible (p ).  However 
not all proteins are stable at low pH, or their catalytic activity may be altered due to                                                                                                                                                60 
altered protonation states of the active site residues. 
Sodium chloride is an important constituent of many protein chemistry buffers as it can 
prevent the protein from precipitating.  This prevention of precipitation may be due to  
solvent counter-ions migrating towards the protein resulting in a layer which repulses the 
co-ions left in solution.  However, as you increase NaCl concentration the conductivity 
of the solution also increases.  The increase in conductivity not only affects the effective 
radio  frequency  power  felt  by  the  sample  but  also  by  the  receiver  coils  of  the 
spectrometer used to record the RF signal.  Thus sensitivity is reduced.  The reduction in 
effective RF power can be partially corrected by increasing pulse width, but this results 
in pulses that are further from ideal with various consequences for the quality of the 
resulting spectrum. 
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Figure 2.21  1D 
1H spectra of unlabelled xDNMT1 CXXCb (10mM deuterated tris 
(hydroxymethyl)aminomethane, 250mM NaCl, pH 7.0) at various temperatures.  Water 
suppression using the method of Hwang and Shaka (1995) 
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2.6.2 Protein size 
In solution NMR, amide 
1H from any unstructured regions of a protein will appear in the 
7-8.5 ppm region of a 1D 
1H spectrum, resulting in a decrease in peak dispersion and 
increase in the overlap of the cross peaks in the spectra.  Shortening of the domain at the 
N- and C- termini can have a pronounced effect on the spectra recorded since the termini 
of protein domains are often unstructured.  In the case of xDNMT1 CXXC domain, 
shortening the construct from both termini had a dramatic effect on the resolution of the 
recorded spectra.  Figure 2.22 shows the differences between the three constructs 
 
  CXXCa 
506FFSEQIEKDAE                      DEDEEVEDVLPEMPSPKKILQGKKKKLE
600 
  CXXCb                               
517                   DEDEEVEDVLPE
584 
  CXXCc              
517                           572 
 
       
517 KENGIKRRRCGVCEVCQQPDCGQCKACQAMLKFGGAGRTKQACM 
         QRRCPNLAVKEA
572  
 
Figure 2.22  Schematic  showing  the  amino  acid  sequences  of  the  three  xDNMT1 
CXXC  constructs.    The  green  box  represents  xDNMT1  CXXCc  whose  sequence  is 
shown below 
 
NMR spectra for the three xDNMT1 CXXC constructs shown above are shown in figure 
2.23.  Both CXXCb and CXXCc show less peak overlap in the 7-8.5 ppm region when 
compared to CXXCa, with the 8.5 – 9.5 ppm region becoming better resolved as the size 
of the construct becomes smaller.  The peak around 0.6 ppm also becomes more intense 
relative  to  other  peaks  in  the  aliphatic  region  as  the  domain  is  shortened  (this  peak 
disappears when the protein is unstructured e.g. upon addition of EDTA to the sample).   
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Figure 2.23  1D 
1H spectra of unlabelled various xDNMT1 CXXC contructs (10mM 
deuterated tris (hydroxymethyl) aminomethane, 250mM NaCl, pH 7.0) Water 
suppression using the method of Hwang and Shaka (1995).  
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SAMPLE PREPARATION & NMR SPECTROSCOPY of hMBD1 CXXC1 
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3.1 Cloning of hMBD1 CXXC1 Domain 
This section describes the strategy used to design hMBD1 CXXC1 constructs, to express 
and purify the hMBD1 CXXC1.  The NMR experiments carried out are also described. 
 
3.1.1 Bacterial transformations 
All  bacteria  used  were  chemically  competent.    Heat  shock  was  therefore  used  to 
transform  the  DNA  into  the  cells.    The  bacteria  were  removed  from  –80˚C  and 
immediately placed on ice to defrost before 1   l (mini prep DNA) or 1.5  l (DNA 
ligation) was added and gently stirred with the pipette tip.  The bacteria were incubated 
on ice for 2 minutes before being heat shocked at 42˚C for 30 seconds and then placed 
back on ice for a further 5 minutes.  300  l 37˚C pre-warmed SOC media was added 
before  the  bacteria  were  incubated  at  37˚C  &  200  rpm  for  1  hour.    For  plasmid 
transformations 50, or  for ligations 350  l of culture was spread onto pre-dried LB-agar 
containing the required selection antibiotics.  The culture was allowed to dry into the 
LB-agar (approximately 15 minutes) before being placed in a 37˚C incubator overnight.  
Single colonies could then be picked the next day for inoculation into LB for plasmid 
purification or protein expression. 
 
3.1.2 Agarose Gel Electrophoresis 
1 gram of multiple purpose agarose (Roche, Cat No. 1388991) was put into a 250 ml 
conical flask containing 100 ml TBE buffer.   The agarose was dissolved by heating in a 
900 W microwave for approx 90 s.  Ethidium bromide was added to the agarose to a 
final concentration of 10  g/ml once it had cooled to approximately 50˚C.  It was then 
poured into the casting tray of the electrophoresis apparatus (BioRad, Cat No. 164-0310) 
containing a sample comb and allowed to solidify at room temperature.  Once the gel 
had set the comb was removed carefully and TBE buffer added to the tank in order to 
cover the gel by approx 5-6 mm.  DNA samples were mixed with 6x loading buffer 
(Promega, Cat No. G1881) then pipetted into the wells.  NEB 2-log ladder (Cat. No. 
N3200S) was added for size referencing before electrophoresis was carried out under 
conditions of constant voltage at 100V for as long as it was required to separate each 
specific sample (30-60 minutes).  Migration of the DNA was detected by fluorescence of 
ethidium bromide bound to DNA under UV illumination 
 
3.1.3 Considerations when choosing domain size to express 
When studying a protein in solution, non-structured areas of a protein are more flexible   66 
than the structured domains.  The flexible unstructured regions will tend to have no long 
range NOEs and when present at the N & C termini of a protein will not contribute any 
information to the overall structure of the protein.  Flexible N- & C- termini will also 
give  rise  to  additional  poorly  resolved  cross  peaks  in  the  NMR  spectra  making 
assignment more difficult.  Thus, it is important to express a domain with minimal N- & 
C-terminal overhangs if possible. 
 
3.1.4 PCR of hMBD1 CXXC1 Domain 
Using  the  sequence  identified  by  Cross  et  al  (1997)  a  BLAST  search  revealed  an 
IMAGE  clone  that  contained  the  cDNA  required  to  amplify  the  hMBD1  CXXC1 
domain.  The clone containing the DNA sequence of interest, GENBANK accession 
number CF552871, was purchased from Geneservice Ltd (clone ID 30529682).  The 
cDNA had been cloned into pCMV SPORT (ampicillin
R) which was transformed into 
chemically competent DH5α E.coli cells (Invitrogen, Cat No.18265-017).  A stock of 
plasmid was prepared by inoculating a single colony into 10 ml of Lauria Broth (LB) + 
100 µg LB and grown overnight at 37ºC in an orbital incubator at 200 rpm.  Plasmids 
were purified by alkali-lysis using a GenElute
TM plasmid mini prep kit (Promega, Cat 
No PLN-350).  PCR primers were designed based on the solution structure of the MLL 
CXXC domain (Allen et al, 2006) in order to minimize flexible non-structured N- & C- 
termini.  Allen et al assigned and calculated the structure for residues V1146 to K1214 
of the MLL CXXC domain but found that only residues R1150-P1201 adopted a well-
defined tertiary structure.  Based on their structure primers were designed to amplify the 
region from MBD1 encoding amino acids 166-222, to give the least amount of flexible 
N- & C- termini (figure 3.1).  The gene fragment was cloned into a pGEX-6P1 (GE 
healthcare, Cat No. 27-4597-01) expression vector containing an N-terminal PreScission 
protease site (Figure 3.2).  PreScission protease is a fusion protein of glutathione S-
transferase and human rhinovirus type 14 3C protease (Habig et al, 1974) allowing a one 
step cleavage/protein elution step when using a GST-resin for purification.   
 
 
Figure 3.1  Amino acid alignment of CXXC domains from MLL and hMBD1 
comparing the sequence used by Allen et al and the domain cloned for this study   67 
 
Figure 3.2  Plasmid map and multiple cloning site of pGEX-6P1 showing the 
PreScission protease cleavage site (GST handbook, GE healthcare). 
 
The PCR primers (figure 3.3) included restriction sites to clone the PCR product into 
pGEX-6P1 so that the CXXC domain would be expressed in frame with the GST tag.    
 
hMBD1 CXXC1 fwd  5’ GGGATCCGAGCAGAGAATGTTTAAG 3’ 
hMBD1 CXXC1 rev  5’ CTCGAGTCAGCTCCTTTCCACAATC 3’  
 
Figure 3.3  Primers for the PCR amplification of hMBD1 CXXC1 domain.  The 
restriction sites used (fwd BamH1, rev Xho 1) are shown in bold with the stop codon 
underlined 
 
PCR primers were ordered from Sigma Genosys and diluted to a stock concentration of 
100  µM.    Amplification  was  carried  out  on  a  Techne  TC-512  thermo  cycler  using 
PfuTurbo®  DNA  polymerase  (Stratagene,  Cat  No.  600250)  with  the  IMAGE  clone 
30529682 as a template.  The DNA template was diluted 1:100 from a plasmid mini prep 
stock. PCR reaction mix was as follows: 
 
1 µl (0.5µg) DNA template 
1 µl of each primer (50µM stock) 
1 µl of dNTP mix (NEB, Cat No N0447S) 
0.5 µl (1.25 units) Pfu Turbo DNA polymerase 
5 µl 5x Pfu Turbo DNA polymerase buffer 
41.5 µl ultrapure water   68 
35 cycles 
MBD1 CXXC1 
PCR 
As PfuTurbo is not a hotstart enzyme, it was added to the reaction after the initial 5 
minutes at 95ºC followed by  
1min 95ºC 
1min 60ºC 
1min 72ºC 
With a final extension of 10 mins at 72ºC producing a product 183bp long.   
 
To purify the DNA, the sample was subjected to agarose gel electrophoresis.  The PCR 
reaction was mixed with loading buffer (Promega, Cat No. G1881) and run on a 1% 
agarose gel (Roche, CAT No 1388991) prestained with 5µl ethidium bromide (stock 
10mg/ml) alongside 2-log DNA marker (NEB, Cat No N3200S) (fig 3.4).  The DNA 
was visualized by detection of ethidium bromide fluorescence upon exposure to ultra 
violet light and excised from the gel.  The DNA was purified from the gel slice using a 
QIAquick gel extraction kit (Qiagen, Cat No 28704) according to the manufacturer’s 
instructions and eluted in 30µl. 
 
 
 
Figure 3.4   Agarose gel electrophoresis negative image of the MBD1 CXXC1 PCR 
product.  M - 2-log DNA marker 
 
3.1.5 Cloning of PCR product into pGEM-T easy 
In order to clone the cDNA fragment into the pGEM-T easy vector (Promega, Cat No 
1360) adenine overhangs (A-tail) had to be created since Pfu Turbo is a proof reading 
enzyme and removes any overhangs.  Taq polymerase (NEB, Cat No M0273S) was used 
in  the  following  reaction  to  add  the  A-tail  to the  PCR  fragment.    The  reaction  was 
incubated for 15 mins at 72ºC. 
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1 µl (5 units) Taq DNA polymerase 
1 µl dATP 4mM stock (Promega, Cat No. U1201) 
1 µl 10x Taq polymerase buffer 
7 µl gel purified DNA 
 
The A-tailed DNA was then cloned into pGEM-T easy according to the manufacturer’s 
instructions and transformed into chemically competent DH5α cells.  Positive clones 
were identified using blue/white selection (see appendix), inoculated into 10 ml LB + 
100 µg/ml ampicillin and grown overnight at 37ºC in an orbital incubator at 200 rpm.  
Plasmids were purified by alkali-lysis as described above.   Cloning into pGEM-T easy 
allowed the digestion of the construct with BamH1 (NEB, Cat No R0136S) & Xho1 
(Promega,  Cat  No  R6161)  to  release  the  MBD1  CXXC1  fragment  with  sticky  ends 
enabling ligation into pGEX-6P1.   pGEX-6P1 was digested with the same enzymes; the 
fragments were then separated by agarose gel electrophoresis and then excised from the 
gel (Fig. 3.5).   The restriction digest which included the following 
 
34µl DNA from standard mini prep elution 
4µl NEB BamH1 buffer 
1µl BSA (10mg/ml stock concentration) 
1µl of BamH1 (20 units) & Xho1 (10 units) enzymes 
 
was incubated for 90 minutes at 37ºC   70 
 
3.1.6 Cloning of MBD1 CXXC1 into pGEX-6P1 
The MBD1 CXXC1 insert and pGEX-6P1 were ligated using NEB T4 Ligase (Cat No 
M202S) according to the manufacturer’s instructions, transformed into DH5α cells and 
spread onto LB agar plates containing 100 µg/ml ampicillin and grown overnight at 
37ºC.    Colonies  were  inoculated  into  10  ml  LB  +  100  µg/ml  ampicillin  and  grown 
overnight at 37ºC in an orbital incubator at 200rpm.  Plasmids were purified from the 
bacteria  using  alkali-lysis  as  described  above  and  digested  with  restriction  enzymes 
BamH1 & Xho1 to identify clones containing an insert of the expected size (fig 3.6).  
Correct clones were sent to Cogenics for sequencing.  Clones with the correct sequence 
were used for protein expression 
 
 
 
V  I 
CXXC1 Fragment 
M1  M2 
Figure 3.5  Agarose gel electrophoresis of the digested pGEX-6P1 vector and  
pGEM-T CXXC1 construct. M1 1KB ladder NEB, M2 100bp ladder NEB V – pGEX-
6P1, I – pGEM-T CXXC1   71 
 
 1           2           3            4          5           6          7           8 
 
 
Figure 3.6  Agarose  gel  electrophoresis  of  a  selection  of  8  putative  pGEX6P1-
hMBD1CXXC1  clones  digested  with  BamH1  and  Xho1.  The  arrow 
indicates the expected position of the CXXC1 fragment. Clones 2, 5, 6 & 
8 show the expected fragment pattern.  M- NEB 2-log ladder. 
 
3.2 Protein Sample preparation 
The pGEX-6P1 system utilizes a GST (Glutathione S-Transferase) tag for purification of 
the target protein on a Glutathione sepharose
TM 4 fastflow resin (GE healthcare, Cat No. 
17-5132-01).    Cleavage  of  the  GST  tag  from  the  target  protein  was  achieved  using 
PreScission Protease (GE Healthcare, Cat No. 27-0843-01). 
 
3.2.1 Expression of the hMBD1 CXXC1 domain 
Based  on  previous  experience  with  the  CXXC  domain  from  xDNMT1  and  the 
publication of the MLL CXXC structure (Allen et al, 2006) pGEX-6P1 CXXC1 was 
transformed into chemically competent Tuner
TM DE3 cells genotype F
– ompT hsdSB (rB
– 
mB
–) gal dcm lacY1 (Novagen, Cat No 70623-4), spread onto LB plates containing 100 
µg/ml ampicillin and grown overnight at 37ºC.  Single colonies were inoculated into 50 
ml of LB containing 100 µg/ml ampicillin in a 250 ml conical flask then incubated 
overnight.   
 
The 50 ml cultures were pelleted by centrifugation at 4300 g for 5 mins at 5000 rpm.  
The supernatant was removed and the pellet resuspended in 5 ml LB which was used to 
inoculate 500 ml of LB containing 100 µg/ml ampicillin in a 2 L conical flask.  The 
bacteria were grown at 37ºC in an orbital shaker, 200 rpm, to an OD600 between 0.6-0.8 
before being cooled to 4ºC.  Protein expression was induced by the addition of 150 µl of 
IPTG (1 M stock) to give a final concentration of 300 µM.  The bacteria were placed 
back in the orbital incubator to express overnight at 13ºC.  For isotopically labelled 
M   72 
protein, the bacteria were grown in 500 ml of M9 minimal media rather than LB.   
 
3.2.2 Purification of hMBD1 CXXC1 domain 
A typical preparation of 4-5 mg of protein required 2 L of bacteria grown in 4x500 ml 
lots.  The bacteria were pelleted by centrifugation for 10 minutes at 4300 g.  The 
supernatant was removed and the bacteria resuspended in phosphate buffered saline 
solution (PBS) pH 7.3 (10 ml per 1 L of culture) then frozen at -20ºC.  To lyse the cells, 
they were first defrosted and warmed to room temperature (RT) before 2 ml of 10x 
BugBusterTM (Novagen, Cat No 70921-5) and 125 units of benzonase® nuclease 
(Novagen, Cat No 70746-3) were added.  The sample was incubated on a roller mixer 
for 20 mins at room temperature (RT).  Soluble and insoluble material was separated by 
centrifugation for 25 mins at 19872 g.   An empty econo-pac column (Bio-Rad, Cat No 
732-1010) was filled with a 3 ml bed volume of FastFlowtm 4 glutathione sepharose and 
equilibrated by washing the resin with 5 bed volumes of PBS pH 7.3.  The supernatant 
was passed through the resin twice which was then washed with 5 bed volumes of PBS 
pH 7.3.  To remove the tag, 80 units of dialysed PreScission was mixed with 3 ml of 
PreScission protease buffer minus EDTA.  To remove EDTA from the PreScission 
protease it was dialysed against 1L 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM 
DTT using a Thermo Scientific Slide-A-Lyzer Dialysis Cassette 7000MWCO (Cat. No. 
66373).  Glycerol was added to the dialysed sample to a final concentration of 20%.  The 
PreScission protease was aliquoted and stored at –20˚CThis was then added to the 
column and the resin gently resuspended before being incubated at 4ºC overnight.  The 
cleaved MBD1 CXXC1 domain was eluted from the column by applying 20 ml of 
elution buffer (see appendix).  Samples of the soluble lysis fraction, the flow through, 
the resin and the elution were analysed by SDS-PAGE (Figure 3.7).  The samples were 
mixed with 4X NuPAGE LDS sample buffer (Invitrogen, Cat No. NP0007) prior to 
being loaded into pre-cast NuPAGE 4~12% bis-tris gels (Invitrogen, Cat No. 
NP0321BOX). The samples were heated to 85 
0C for 10 min with 90 mM β-
Mercaptoethanol before loading. Protein markers (BioRad, Cat No. 161-0373) were 
diluted with two volumes of water and one volume of NuPAGE LDS sample buffer and 
10  l was loaded. The gel was run at 200 V constant voltage for 35 minutes. The protein 
bands were visualized after staining the gel with approximately 100 ml of coomassie 
stain for 5 to15 min followed by destaining in 100 ml of destaining buffer overnight at 
room temperature 
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Using the conditions described above for expression and purification of the protein 
resulted in an approximate yield of 4-5 mg of purified soluble protein when measured by 
Bradford assay which could be concentrated and buffer exchanged (chapter 3.2.3).       
 
 
Figure 3.7  SDS-PAGE analysis of the expression and purification of MBD1 CXXC1 
domain expressed in Tuner
TM DE3 cells. The image has been edited to place lanes F, R 
and E together since they were spaced out on the original gel.    
 
3.2.3 Sample concentration and buffer exchange 
For NMR spectra to be recorded within a sensible time, the protein concentration within 
the  NMR  sample  must  be  at  least  0.5  mM.    Since  experiments  can  take  place  at 
temperatures  which  make  the  protein  more  liable  to  go  off  (precipitation,  protease 
digestion,  unfolding)  the  shorter  the  experimental  time  taken  the  better.    More 
concentrated samples produce better signal to noise enabling this.  Using a vivaspin20 
5kDa molecular weight cut off spin concentrator (Sartorius Stedim, Cat No VS2012) it is 
possible to both buffer exchange and concentrate the sample to the appropriate volume 
(500 µl).  The concentrator was washed with water to remove the glycerol preservative 
before  addition  of  the  eluted  protein.    The  sample  was  concentrated  to  500  µl  by 
centrifugation at 3056 g and 10ºC.  NMR buffer was added slowly to a total volume of 
20 ml and the process  repeated twice  achieving  a 1600 fold dilution of the original 
buffer.  The purification of MBD1 CXXC1 resulted in NMR samples of between 1-
1.25mM 
M  S  F  R  E 
M – Biorad prestained molecular weight 
marker 
S – 20 µl soluble lysis fraction 
F – 20 µl flow through fraction 
R – 20 µl of resin after washing 
E – 10 µl of eluted MBD1 CXXC1 protein 
   74 
The  concentrated  sample  was  centrifuged  at  13000  rpm  for  5mins  in  a  bench  top 
microcentrifuge to remove any particles before 30 µl of D2O was added.  D2O provides a 
deuterium lock signal for the NMR spectrometer.   The sample was made up to 600 µl 
with ultrapure water before being gently pipetted into an NMR tube (Wilmad 535-pp or 
Novell S607)   
 
3.3 NMR spectroscopy  
Data was recorded on Bruker AVANCE 600  MHz & 800MHz NMR spectrometers, 
equipped with 5 mm TCI cryoprobes.  NMR experiments were carried out using 1 mM 
protein samples except for DNA titration (100 µM).  The experiments carried out are 
shown in table 3.1.  1D and 2D NOESY, TOSCY experiments unlabelled protein was 
used.  For COSY (and another 2D NOESY) experiment, NMR buffer was made with 
D20 in place H20.  3D TOCSY-HSQC and NOESY-HSQC, 
15N labelled protein was 
expressed  using  M9  minimal  media  supplemented  with 
15N  labelled  ammonium 
chloride.  All experiments were carried out at a temperature of 293 K. 
 
3.3.1 DNA Titration of hMBD1 CXXC1 
A Palindromic DNA oligonucleotide of 12 bp length (12mer -GCTTACGTAAGC ) was 
purchased  from  Sigma  Genosys  (reverse  phase  HPLC  purified).    The  oligo  was 
resuspended  in  nuclease  free  water  (promega)  to  a  concentration  of  84  uM  per  ml.  
Annealing of the oligo was performed by heating the sample to 95˚C then allowing it to 
cool slowly to room temperature.  The 12mer was then aliquoted into 600 µl (50  M) 
samples before being lyophilized.  This allowed the DNA to be mixed with the NMR 
sample  without  decreasing  the  concentration  of  the  NMR  sample.    An  HSQC  was 
carried out at protein:DNA concentration ratios 1:0, 1:0.5, 1:1, 1:3 to investigate the 
DNA binding ability of the hMBD1 CXXC domain 
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    Dimension 1      Dimension 2      Dimension 3         
Experiment  Nuc  TD  SW  Nuc  TD  SW  Nuc  TD  SW  RD 
ms  NS  WS 
100ms 
NOSEY 
1H  2048  8503 
1H  2048  7001        1.0  32  ES 
200ms 
NOSEY 
1H  2048  8503 
1H  2048  7001        1.0  32  ES 
100ms 
NOSEY* 
1H  2048  9615 
1H  1024  9596        1.0  32  ES 
60 ms D2O 
NOSEY 
1H  2048  8503 
1H  2048  7000        1.0  16  PS 
60 ms 
TOCSY 
1H  2048  8503 
1H  2048  7001        1.0  32  ES 
COSY 
1H  2048  8503 
1H  2048  7001        1.0  32  WG 
D2O COSY 
1H  2048  8503 
1H  2048  6999        1.0  24   
HSQC* 
1H  2048  12820 
15N  128  1702        1.0  8  WG 
HSQC + 
DNA 
1H  2048  9615 
15N  128  1277        1.0  32  WG 
HSQC-
NOSEY* 
1H  1024  11160 
1H  512  11160 
15N  128  1702  1.0  8  WG 
HSQC-
TOCSY* 
1H  1024  11160 
1H  256  11160 
15N  128  1702  1.0  8  WG 
 
Table 3.1 Acquisition parameters of NMR experiments (Bruker AVANCE 600 MHz unless * then Bruker AVANCE 800 MHz) used for resonance 
assignment and structural restraints collection. Nuc: Nucleus, TD: time domain points (complex), SW: sweep width in Hz, RD: relaxation delay, NS: 
number of scans, WS: water suppression, WG: water gate, ES: excitation sculpting, PS: presaturation, ms: milliseconds,                                                                                                                                                 76 
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
 
 
CHEMICAL SHIFT ASSIGNMENT AND STRUCTURE CALCULATION OF 
hMBD1 CXXC1 
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4.1 NMR protein structure calculation 
This chapter shows how the chemical shifts of the resonances of hMBD1 CXXC were 
assigned  using  CcpNMR  analysis  software  (Vranken  et  al,  2005),  how  distance 
restraints were derived from NOESY spectra and how ARIA (Ambiguous Restraints for 
Iterative Assignment) was used for structure calculations.    
 
4.2 Is the protein is structured? 
NMR  experiments  used  to  generate  spectra  for  chemical  shift  assignment  and  to 
calculate  NOE  distance  restraints  takes  significant  time  to  complete.    Before  such 
experiments  are  undertaken  the  sample  must  be  checked  to  evaluate  whether  it  is 
structured.  For an unlabeled sample, the observation of particular features in a 1D 
1H 
spectrum  is  normally  sufficient  to  suggest  that  a  sample  is  structured.    The  1D 
1H 
spectrum of unlabeled hMBD1 CXXC1 (figure 4.1) suggests that the protein sample is 
folded due to the overall dispersion of chemical shifts in the methyl (0-2ppm) and amide 
(8.5-10ppm) regions and the 
1H line widths.    The 1D 
1H experiment is relatively short, 
typically 8 seconds for a 0.5mM hMBD1 CXXC1 sample, therefore it is ideal to run, to 
be sure the sample has not unfolded or precipitated, between the longer 2D TOCSY, 
NOESY, COSY experiments. 
 
For larger proteins, >10kDa, the 1D 
1H NMR experiment is not ideal due to potential 
overlap  of  chemical  shifts  and  broader  line  widths.    In  these  situations  isotopically 
labeled  proteins  are  required  due  to  increasing  overlap  in  homonuclear  2-D  spectra.                                                                                                                                                   78 
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4.3 Sequence specific resonance assignment of hMBD1 CXXC1  
The relatively small size of the CXXC domain lends itself to structural determination 
though homonuclear NMR, thus not incurring the high cost associated with 
13C & 
15N 
labeling  or  problems  of  achieving  sufficient  quantity  of  protein  from  growth  in  M9 
minimal  media.  Sequence  specific  resonance  assignment  of  hMBD1  CXXC1  was 
attempted using 2D NOESY & TOCSY spectra according to the method described by 
Wutrich  et  al,  and  although  significant  stretches  of  amino  acids  could  be  assigned, 
crucially the remaining resonances could not be assigned due to features of the spectrum 
as set out below.    
 
4.3.1 Overlapping regions make sequential assignment difficult 
The TOCSY and NOESY spectra for hMBD1 CXXC1 are mainly well dispersed except 
for a part for the Hα-HN correlation region where there is significant overlap (figure 4.2).  
This region, centered around 4.3, 8.3 ppm proved problematic for sequential assignment 
of the backbone HN to Hα atoms.  An example of the difficultly in assigning crosspeaks 
in overlapped spectra is shown in figure 4.3. Figure 4.3 shows the TOCSY Hα-HN and 
aliphatic-HN crosspeaks for arginines 169 & 173.  Arginines 169 & 173 share the same 
HN chemical shift which makes it difficult to distinguish which cross peak belongs to 
which amino acid.  It was also not possible to assign sidechain cross peaks to either of 
these arginines.   
 
Not only did it prove difficult to assign certain amino acids using only 2D spectra but it 
was  also  difficult  to  sequentially  assign  spin  systems.    As  previously  described  in 
chapter two (p49) side chains have characteristic crosspeak pattern and chemical shift 
patterns which allow spin systems to be assigned to an amino acid type.  This allows 
spins  systems  to  be  labelled  as  e.g.  a  cysteine  or  glycine  without  assigning  it  in 
sequence.  For example, the amino acid sequence of hMBD1 CXXC1 contains only one 
histidine. Therefore it was possible to identify which crosspeaks belonged to histidine 
200.    However,  using  only  2D  homonuclear  NOESY  &  TOCSY  spectra  is  was  not 
possible to assign the adjacent residues 199 and 201.           
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Figure 4.3  TOCSY  strips  for  the  partially  assigned  arginine  169  &  173  residues.  
Annotated with assignments made using 
15N labelled protein   
 
4.3.2 Assignment of phenylalanine side chains 
Using D2O rather than H2O as the NMR sample solvent means the HN are replaced by a 
deuteron due to proton exchange with the solvent.  The DN no longer produces a 
1H 
NMR signal and therefore there are no cross peaks in the HN region of the spectrum.  
However the cross peaks from aromatic sidechains remain visible (figure 4.4).  Of the 3 
types of aromatic protons in phenylalanine, only Hδ is expected to give strong NOESY 
cross peaks to Hα or Hβ, with Hε and Hζ showing weaker signals.  hMBD1 CXXC1 
only contains two phenylalanines.  Thus, with the sequence specific assignment of P207 
from C208 this allowed for the rapid assignment of P207 sidechain.  The remaining 
crosspeaks were therefore where assigned to P171.       
a) Hα- HN chemical shift region  b) Aliphatic-HN chemical shift 
region 
δ
 1H 
(ppm) 
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Figure 4.4  Strips for the NOESY of hMBD1 CXXC1 recorded in D20 showing cross 
peaks of 171F & 207F.  A, D2O NOESY only (aqua) B, D2O NOESY overlaid with the 
NOESY experiment carried out in H2O (red). 
 
Because  complete  resonance  assignment  could  not  be  achieved  using  solely 
homonuclear data, 
15N hMBD1 CXXC1 was prepared and 3D HSQC-TOCSY & HSQC-
NOESY was recorded 
 
4.3.3 Assignment using 3D spectra 
Assignment of cross peaks in 2D spectra is a very labour intensive process.  Any one 
horizontal or vertical at a particular chemical shift can have cross peaks belonging to 
more  than  one  amino  acid  as  figure  4.3  shows.  By  moving  through  the  nitrogen 
dimension  in  3D  HSQC-TOCSY  &  HSQC-NOESY  spectra  we  can  distinguish  spin 
systems based on their nitrogen chemical shift.  For example, R169 and R173 that have 
very similar HN chemical shift, their spin systems could be more completely assigned 
δ
 1H 
(ppm) 
 
δ
 1H (ppm) 
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using 3D HSQC-TOCSY & HSQC-NOESY since they have different nitrogen chemical 
shifts (figure 4.5).  
 
 
Figure 4.5 
15N HSQC of hMBD1 CXXC1 showing different nitrogen chemical shifts 
for R169 and R173 
 
Not only do isotopically labeled samples allow the use of 3D experiments to help resolve 
overlapped regions but it also allows the use of analysis’s (Vranken et al, 2005) semi 
automated linking of spin systems.  When assigning cross peaks to a particular amino 
acid or spin system we look for specific correlations in the NOESY spectrum to help 
qualify the assignments e.g. HN to Hα NOE cross peaks for i to i+1, NOE cross peaks 
between sidechain and HN for i to i+1.  The software can automatically look for possible 
matches.  For example, starting from C176 (figure 4.6), analysis will look for NOE cross 
peaks assigned to the HN of other spin systems which match the chemical shifts of the 
assigned C176 TOCSY cross peaks.  As the residue following C176 is G177 we can 
look for cross peaks at a particular chemical shift amongst the matching spin systems.  
For a glycine we would expect to see 2 TOCSY cross peaks correlating both Hα protons 
to the HN proton. Once the next amino acid is identified the software can then be used to 
search for the next spin system to match to it.   
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Assignment of H-H cross peaks in the HSQC-TOCSY spectrum allows the assignment 
of the N-H  cross peak  in the 
15N-HSQC.  The complete  assignment of the hMBD1 
CXXC1 
15N-HSQC is shown in figure 4.7 which shows well dispersed peaks for most 
amides as well as nitrogen bound proteins in the side chains of glutamines 168, 183, 197 
and arginines 213 & 214.  Amino acids G162, M170, and H200 are unassigned in the 
HSQC.  Although there are still overlapped peaks in the 8.25ppm 
1H region there is 
sufficient  dispersion  in  the  15N  chemical  shift  around  120ppm  to  resolve  the  cross 
peaks.  Also present are cross peaks which can be assigned to a minor form of the 
protein.  The minor form of the protein may be due to proteolysis, loss of a zinc ion or 
an incorrectly folded version.  Although there are N-H correlations from the minor form 
there  are  no  visible  cross  peaks  in  the 
15N-HSQC-TOCSY  or 
15N-HSQC-NOESY 
spectra.  
 
Using NMR experiments listed in table 3.1 (p75) a near complete assignment of hMBD1 
CXXC1 was possible.  Resonances that could not be assigned to cross peaks are listed in 
table 4.1.  These amino acids are found in unstructured regions of the hMBD1 CXXC1 
domain.   
 
Amino acids  Unassigned protons 
R 169  Nε Hε 
F 171  γ 
R 173  Nε Hε 
H 200  Nδ1 Nδ2 
R 212  Nε Hε 
R 214  Nε Hε 
R 221  Nε Hε 
 
Table 4.1  list of protons and their amino acids that could not be assigned 
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Figure 4.6  Strips  from  3D  NOESY  (blue)  &  TOCSY  (green)  spectra  showing 
sequential assignment of amino acids C176 to C179 in hMBD1 CXXC1.  The dashed 
line shows the sequential links involving Hα, while the red arrows links NOE cross 
peaks correlating C176 Hβb to G176 HN and G177 HN 
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4.4 Structure calculation of hMBD1 CXXC1 using ARIA 
Since the majority of restraints for NMR structure calculations are provided by NOESY 
derived distance restraints, the cross peaks within the spectrum have to be assigned to a 
particular resonance.  However, due to the large population of protons within a protein 
many protons may share the same chemical shift so there may be several assignment 
possibilities for each NOE cross peak.  Manual assignment is a time consuming process 
which may not provide an accurate structure due to mis-assignment.  In order to speed 
up the process and reduce the risk of mis-assignment, structure calculations were carried 
out  using  the  program  ARIA  2.2  (Ambiguous  Restraints  for  Iterative  Assignment) 
(Rieping et al, 2007).  ARIA does not perform the structure calculations itself but drives 
the  calculation  of  structures  through  the  use  of  ambiguous  distance  restraints 
(unassigned crosspeaks which may have more than one contributing resonance) in an 
iterative structure calculation scheme.   Structures are calculated using the program CNS 
(Crystallography  &  NMR  System)  (Brunger  et  al,  1998),  ARIA  then  analyzes  the 
conformers  obtained  in  order  to  update  the  restraints  and  obtain  a  set  of  improved 
conformers.    During  distance  restraint  generation,  non-degenerate  prochiral  chemical 
shifts e.g. methylene protons or the methyl groups of valine & leucine are arbitrarily 
stereospecifically assigned.  This can result in errors if the wrong member of a prochiral 
pair is chosen for a particular restraint.  To work around this, ARIA applies a floating 
chiral  assignment  testing  both  alternatives  during  structure  calculation.    The 
conformation with the lowest energy is accepted for each prochiral centre.     
 
Distance restraints derived from NOESY cross peaks can be generated in two ways: 
restraints can be generated by ARIA itself or restraints can be generated in Analysis and 
imported into ARIA.  Both methods were tried for structure calculations as ARIA cannot 
use spin diffusion correction with restraints generated in Analysis. 
 
4.4.1 Structure calculation using constraints generated by Analysis 
Ambiguous  distance  constraints  were  generated  in  Analysis  using  the  shift  match 
restraint function.  This function generates a constraint list based on user defined input 
data.  Since the structure of the hMLL CXXC (Allen et al, 2006) domain was known it 
was hypothesized that certain secondary structures present would also be seen within the 
structure of the hMBD1 CXXC1 domain.  Amino acids 1170-1173 of hMLL CXXC 
form an alpha helix incorporating two cysteines from the second CXXCXXC cluster.  
Since the corresponding residues in hMBD1 CXXC1, 187-190, had strong NH
i to NH
i+1                                                                                                                                                88 
and weak NH
i to Hα
i+1 NOESY resonances suggesting it was likely to be an alpha helix.   
Since the average distance of N-H1
i to N-H
i+1 in an alpha helix is 2.8Å, the average NOE 
intensity of N-Hi to N-Hi+1 cross peaks for amino acids 191-195 should approximately 
correspond to a distance of 2.8Å.  Reference NOE intensities for two 2D NOESY and 
one 3D HSQC-NOESY experiments were calculated.  Parameters used for generating 
constraints  are  set  out  in  Table  4.2.    To  calculate  the  distance  constraints  for 
unambiguous cross peaks the same parameters were used. 
 
Ref. Distance  2.8Å     
Distance function  Intensity^ –1/6     
Intensity type  Height     
Max ppm tolerance  F1 0.05  F2 0.05  F3 0.4 
Min ppm tolerance  F1 0.05  F2 0.05  F3 0.4 
 
Table 4.2  Parameters used for generating distance constraints using CcpNMR.   
Analysis software.  F1 – direct proton dimension, F2 – indirect proton dimension, F3 – 
Nitrogen Dimension 
 
The problem with this method of distant constraint generation is that it is not currently 
possible to subsequently use ARIA’s spin diffusion correction algorithms to recalibrate 
the restraints based on the calculated structure.  For structures calculated from these 
restraints NOE energies failed to dip below 180 kJ mol
-1 and it was not possible to obtain 
structures without violations below 0.5Å.  Persistent violations above 0.5 Å included 
intra-residue Valine HN to methyl groups and Histidine HN to β hydrogens.  Currently 
ARIA 2.2 does not support spin diffusion correction (chapter 4.4.4 p87) when importing 
distance constraints generated in Analysis.   
 
4.4.2 Structure calculation using constraints generated by ARIA 
In  order  to  use  spin  diffusion  correction  during  structure  calculation,  the  assigned 
chemical shift list and crosspeaks were imported from Analysis into ARIA for each of 
the  NOESY  spectra.      The  tolerances  for  direct,  indirect  proton  and  heteronuclear 
dimensions were set to 0.025, 0.025 and 0.25 respectively.  These values differ from the 
tolerances used in analysis due to the way they are used.  In Analysis the tolerance is the 
total distance across the crosspeak where as in ARIA the tolerance is set from the centre 
of the cross peak.  Therefore if the same tolerances used in Analysis for generating                                                                                                                                                89 
constraint  lists  were  to  be  used  in  ARIA,  ARIA  would  produce  significantly  more 
constraints.  This would likely result in the generation of poor structure ensembles. 
 
Spin diffusion correction requires the input spectrometer frequency, mixing time and 
molecule  correlation  time  into  the  ARIA  project  for  each  spectrum.    Molecule 
correlation  time  was  worked  out  using  stokes  law.    The  hydrodynamic  radius  was 
estimated from molecular weight.  
 
4.4.3 Additional restraints used by ARIA during structure calculations 
In addition to the distance restraint information generated  from the NOESY spectra, 
restraints specifically for the co-ordination of each of the zinc ions by 4 cysteine residues 
were included during structure calculations.  In order to use zinc co-ordination restraint 
information, one of the cysteines involved in each cluster was defined as residue type 
CZN  (cysteine  +  zinc  ion)  and  the  remaining  3  cysteines  CYS  in  Analysis.    This 
involved the addition of residue definition files and changing the residues from CYS to 
either CZN or CYS of the protein sequence located in the molecule description.  To 
proceed with the calculation, the ARIA CNS protocol file was modified by the addition 
of a code patch.  This patch, provided by the ARIA programmers, defined the bond 
lengths between the sulfur atoms of the cysteines and the zinc ion as well as the bond 
angles (table 4.3).  Structure calculations without the zinc co-ordination restraints were 
also carried out to verify which cystines clustered together.       
 
Atoms  Bond Length  Bond Angle 
S  Zn  2.3 Å   
Cα – Cβ - S    114.3558 
Cβ - S - Zn    109.5000 
Hβ - Cβ - S    107.9185 
S – Zn - S    109.5000 
 
Table 4.3  Additional  restraints  used  by  ARIA  for  zinc  co-ordination  by  four 
cysteine residues.  S, sulfur; Zn, zinc. 
 
Restraints generated from residual dipolar couplings, J couplings, dihedral angles, and 
disulphide bridges, can also be used during structure calculations by ARIA in order to 
build a more refined structure that can be produced by NOESY distance restraints alone.                                                                                                                                                90 
4.4.4 Spin diffusion 
The choice of mixing time in a NOESY experiment is governed by a number of facts.  A 
NOESY experiment with a long mixing time has the advantage of no zero-quantum 
peaks (artifacts present  in the NOESY spectra  from  J-coupled peaks, such as ortho-
protons on a ring).  Long mixing times allow for multiple magnetization transfers which 
distort  cross  peak  intensity  to  distance  relationship.    This  multiple  magnetization 
transfer, known as spin diffusion, can affect cross peaks between pairs of protons both 
close and far apart in space.  Protons close in space can be affected by back transfer of 
magnetization I1→ I2→ I1 reducing the intensity of NOE cross peak that would normally 
result.  Protons far apart in space can be affected by an indirect transfer of magnetization 
I1→ I2→ I3, increasing the intensity of the cross peak that would normally result or 
create  a  cross  peak  that  would  not  normally  exist  in  the  absence  of  spin  diffusion.  
Therefore, the mixing time needs to be long enough to let the NOE build up and allow 
zero-quantum effects to decay but short enough to minimise the chance of spin diffusion. 
As discussed in section 2.2.1 (p44) the NOESY experiment utilises dipolar interactions 
between two spins ≤5 Å apart.  The intensity of these cross peaks is used for calculating 
distance  restraints.    If  left  uncorrected,  spin  diffusion  leads  to  inaccurate  distance 
restraints between protons leading to overly constrained and incorrect protein structures. 
Spin diffusion correction in ARIA (Linges et al, 2004) is based on the calculation of a 
theoretical transfer matrix from the set of structures produced in  each  iteration. The 
theoretical intensity values are then used to calibrate the experimental intensities and to 
correct the distance target. The calibrated intensities can be then used to estimate the 
error. 
 
4.4.5 Iterative structure calculation scheme 
ARIA uses an iterative strategy for structure calculations (table 4.4).  For the structure 
calculation  of  hMBD1  CXXC1,  unambiguous  (manually  assigned  resonances)  and 
ambiguous restraints were used from the start, iteration 0.   When structures have been 
calculated,  a  user  defined  subset  from  the  ensemble  is  chosen  on  the  basis  of  their 
potential energy.  These structures are used to filter the restraints (partial assignment 
filter) based on their contribution to the intensity of the crosspeak.  Restraints which are 
above  the  threshold,  a  percentage  of  the  total  contribution,  are  removed  from  the 
restraint list.  Restraints that are not filtered out are used to recalibrate the spectra based 
on  their  average  distance  chosen  from  the  subset  of  structures.    The  restraint  list  is 
checked  again  for  violations  using  the  new  intensity  -  distance  matrix.    In  the  next                                                                                                                                                91 
iteration structures are calculated based on the new restraint list created at the end of the 
previous  iteration.    Each  iteration  subsequently  reduces  the  partial  assignment  filter 
threshold and violation tolerance.  This process is repeated for a user defined number of 
iterations.  In order to improve the recalibration of restraints, spin diffusion correction 
was included from iteration 3 using a distance cut off of 6 Å.  The cut off is used to filter 
the calculated intensities used for correction, by including only those corresponding to a 
distance smaller than the distance cutoff value.  Assignment statistics are carried out on 
a user defined number of structures in each iteration which are selected on the basis of 
having lowest total energy.  The number of structures chosen to be used depends on the 
number of structures calculated in each iteration and the range of total energies of the 
ensemble.  The greater the number of structures calculated the greater number can be 
used  for  analysis.    In  the  initial  round  of  structure  calculations  where  assignment 
mistakes and artifact peaks are likely to be present there is no advantage in generating a 
large number of structures during each iteration.  Structure calculation can be a time 
consuming process depending on the number of processors that can be accessed.  With 
this in mind the total number of structures in each iteration generated in the initial round 
of structure calculations was set to 20.  
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Iteration 
Restraints 
Partial 
Assignment 
Filter 
Spin 
diffusion 
Violation 
Tolerance 
Å 
No. of 
Structures 
 
No of 
structures 
used for 
analysis 
0 
Original 
restraints 
1.0  No  10000  20  7 
1 
Checked 
restraints from 
round 0 
0.999  No  5.0  20  7 
2 
Checked 
restraints from 
round 1 
0.99  No  3.0  20  7 
3 
Checked 
restraints from 
round 2 
0.99  Yes  1.0  20  7 
4 
Checked 
restraints from 
round 3 
0.99  Yes  1.0  20  7 
5 
Checked 
restraints from 
round 4 
0.96  Yes  1.0  20  7 
6 
Checked 
restraints from 
round 5 
0.93  Yes  0.3  50  7 
7 
Checked 
restraints from 
round 6 
0.9  Yes  0.3  100  7 
8 
Checked 
restraints from 
round 7 
0.9  Yes  0.3  200  20 
 
Table 4.4  Iterative  strategy  used  for  hMBD1  CXXC1  structure  calculation  using 
ARIA.   
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For speed, structures are typically calculated “in vacuum” which can result artifacts as a 
result of the simplified treatment of non-bonded forces and missing solvent contacts.  
ARIA  provides  the  option  of  refining  structures  in  a  shell  of  water  molecules  for  a 
defined number of structures from the final iteration with a full molecular dynamics 
force field incorporating electrostatics (Linge et al, 2003).  This refinement helps to 
avoid unrealistic side chain packing and unsatisfied hydrogen bond donors or receptors.  
To ensure there are no systematic differences that could influence validation results, the 
force fields used for water refinement (file PARALLHDG 5.3) are consistent with the 
force fields used for structure calculation and validation.      
 
4.4.6 Analysis and report files 
At  the  end  of  each  iteration,  ARIA  generates  various  output  files  which  report  the 
analysis ARIA carried out for each iteration. 
 
1. noe_restraints.unambig & noe_restraints.ambig:  These files contain all the 
unambiguous  and  ambiguous  restraints,  noting  the  reference  cross  peak,  the 
restraint bound, the distance found in the ensemble and the result of the violation 
analysis 
2. noe_restraints.violations: lists just the violated restraints containing the same 
detail as for 1. above 
3. noe_restraints.assignments: provides information on wither the assignments 
stem from fully, partially or unassigned cross peaks. 
4. noe_restraists.merged: lists all restraints discarded by the merging procedure. 
5. report: summarises analysis of the restraint lists and the structure ensemble. 
 
In addition to these reports, ARIA can export the last iteration of structures (and water 
refined structures) to Analysis, a peak list of the assignments (for each spectrum) and a 
list  of  violated  restraints  which  were  not  used  for  structure  calculation  in  the  final 
iteration.  Ambiguous assignment of resonances by ARIA is not infallible since noise 
and artifact peaks can be assigned if they match the chemical shift data.  ARIA can also 
mis-assign ambiguous peaks if any manual assignments are incorrect.  This is due to 
manual assignment forcing ARIA to satisfy the distant restraint calculated from the NOE 
crosspeak driving structure calculations in a specific way.  After each round of structure 
calculation violated peaks were inspected and either manually assigned or removed from 
the  peak  list.    Noise  and  artifact  peaks  are  removed  while  mis-assigned  peaks  were                                                                                                                                                94 
corrected.  Mis-assignment can be a problem if the tolerances for automatic assignment 
are set too low (see chapter 4.4.6) which can for example allow intra-residue cross peaks 
to be assigned as inter-residue.     
 
Once calculations started to yield structures that have low energies then the number of 
structures  calculated  in  iteration  8  was  increased.    An  increase  in  the  number  of 
structures  calculated  will  increase  the  number  of  low  energy  structures  within  the 
ensemble.  For example, if 20 structures are calculated they may not all be statistically 
similar  even  though  they  fit  the  experimental  data.    However,  if  200  structures  are 
calculated, then 25 structures of the ensemble maybe of significant similarity.  Once 
NOE energies had reached a sufficiently low level, < 100 kJ mol
-1, water refinement was 
introduced  to  the  calculation.    Since  the  water  refinement  step  introduces  new 
constraints, the overall energies of the ensemble tend to increase.  Therefore there is no 
advantage in introducing this step in earlier round of calculations when the structures are 
not near converging.   When calculation produced structures of significantly low NOE 
energies  <50  kJ  mol
-1  and  no  more  improvement  could  be  made  using  the  current 
restraints, analysis was carried out to verify the precision and accuracy of the structures. 
Using NMR to generate a unique three dimensional structure is not possible because 
multiple  structures  can  be  calculated  that  are  consistent  with  restraints  derived  from 
experimental data.   This is compounded by less defined  regions of protein structure 
which are dynamic in solution.  Thus an ensemble of structures with the lowest energies 
can be produced to show a meaningful representation of the structure consistent with the 
experimental data. 
 
 
 
.   
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CHAPTER FIVE 
 
STRUCTURE AND FUNCTIONAL ANALYSIS OF HMBD1 CXXC1 
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5.1 Overview 
This chapter reports the structure of hMBD1 CXXC1 and discusses its implications in 
relation  to  the  other  known  CXXC  structures.    The  CXXC  domains  that  have  been 
shown  to  bind  non-methylated  CpG  contain  a  conserved  amino  acid  sequence 
361KFGG
364 and other conserved residues (D358 & Q370) as found in hMBD1 CXXC3.  
hMBD1 contains, depending on alternative splicing, 2 (55kDa) or 3 (66kDa) CXXC 
domains (Fujita et al, 1999, Jørgensen et al, 2004) with only the third CXXC domain 
capable of binding non-methylated CpG (Fujita et al, 2000 & Jorgensen et al, 2004).  
Recently,  the  solution  structure  of  the  MLL  CXXC  domain  in  complex  with  DNA 
(Cierpicki et al, 2009) and the crystal structure of DNMT1 CXXC (Song et al, 2010) 
have been solved revealing the amino acids responsible for DNA contact.  Comparison 
of these structures to hMBD1 CXXC1 reveals why hMBD1 CXXC is unable to bind 
non-methylated CpG.      
  
5.1.1 The solution structure of hMBD1 CXXC1 
The  hMBD1  CXXC1  ensemble,  comprising  20  lowest  energy  of  25  water  refined 
structures (figure 5.1), shows a well defined backbone region for residues 173-196 & 
208-218, with the N- & C- termini and residues 197-207 poorly defined. RMSD was 
calculated  for  each  residue  using  CcpNMR  Analysis.    Analysis  uses  singular  value 
decomposition (SVD) to calculate an optimum rotation for two coordinate sets with co-
located centroids. Each atom is weighted, both for the SVD and centroid calculation. 
There are multiple rounds of superimposition to get the ensemble from pairwise model 
comparison and to better refine the weights. Initially the weights come from the atomic 
masses,  but  in  the  later  stages  of  the  alignment  the  weights  come  from  the  atomic 
RMSDs calculated in the earlier round. Accordingly, the dissimilar parts have  
Proportionately little influence on the final ensemble. Figure 5.2 shows the per residue 
RMSD for the hMBD1 CXXC1 ensemble and the number of inter-residue NOEs from 
the 
15N NOSEY.  Only the 
15N NOSEY was used because the peak list imported from 
ARIA has less ambiguouity than the 2D 
1H NOESY giving a truer representation of 
NOEs  used.    Comparison  of  the  number  of  inter-residue  NOEs  and  RMSD  of  each 
residue reveal that the defined structured regions of the ensemble are characterized by a 
high number of inter-residue NOEs per residue while the N- and C- termini have very 
few inter-residue NOEs that consist mainly of short range, sequential correlations 
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Figure 5.1  A stereo view of the ensemble of 20 lowest energy of 25 final hMBD1 
CXXC1 solution structures superposed on the Cα of residues in well-defined regions 
(residues 175 to 196 & 208 to 217).  The less well defined loop (residues 197 to 207) is 
blue with the two cysteine clusters coloured red and green (Figure prepared using 
PyMol) 
 
 
 
. 
N 
C                                                                                                                                                98 
160 170 180 190 200 210 220 230
0
5
10
15
20
R
M
S
D
 
(
Å
)
160 170 180 190 200 210 220 230
Residue number
0
10
20
30
40
50
60
N
o
.
 
N
O
E
s
 
 
Figure 5.2   A. Per residue backbone and all atom RMSD for the final 25 hMBD1 
CXXC1 structures.  Red bars, backbone; black bars, all atom.  RMSD calculated using 
CcpNMR Analysis 2.1.5. B. Number of per residue NOE assignments from 
15N-NOESY 
generated by ARIA for structure calculations in iteration 8.   
 
 
 
 
 
A 
B                                                                                                                                                99 
5.1.2 Precision of the ensemble of hMBD1 CXXC1 structures 
To  be  confidant  that  the  ensemble  of  structures  is  an  accurate  representation  of  the 
experimental data the similarity of the structures was assessed by calculation of the Root 
Mean Squared Deviation (RMSD) of the atomic coordinates of each structure.   It is 
possible to calculate the RMSD by superposition on a selected structure (biased) or by 
global minimization of all fits (complete intensity).  However, by using an unbiased 
mean the calculation of the RMSD is not forced on one structure which may not be the 
most accurate representation of the ensemble.   To calculate the unbiased mean structure, 
the unweighted mean program UWMN (Hartshorn and Caves, University of York) was 
used.  UWMN creates a matrix containing the average distances between atoms in the 
ensemble of structures.  Since this matrix cannot typically be projected into cartesian 
space perfectly, the matrix is projected into multi-dimensional space and orientated so 
that when it is projected back into three dimensions the mean structure is calculated with 
the  least  loss  of  structural  information.    The  differences  between  the  mean  and  the 
structures are listed as well as the average RMSD to the unbiased mean of the ensemble 
which is listed in table 5.1 
 
 
RMSD to the unbiased mean structure (Å) 
 
Heavy atoms 
 
1.143 
 
Backbone atoms 
 
0.854 
 
Table 5.1   RMSD of the final structures in the ensemble calculated to an unbiased 
mean.  RMSD calculated for residues 175-196 & 208-217.   
 
5.1.3 Geometric analysis of the ensemble of hMBD1 CXXC1 structures 
The geometric quality of an NMR structure can be validated by the distribution of the 
backbone (φ and ψ) side chain (χ1) torsion angles (Morris et al, 1992).  The φ angle is 
the dihedral angle between the HN and Cα, the ψ angle is the dihedral angle between the 
Cα and carboxylic carbon. The geometric quality of a  structure can be analysed the 
program using Procheck-NMR (Laskowski et al, 1996).  Procheck-NMR assesses the 
stereochemical quality of structures by comparing them with the known stereochemical 
properties  of  well  refined,  high  resolution  X-ray  structures.    Therefore,  Procheck                                                                                                                                                100 
assesses how normal, or how unusual, the geometry of the residues in a given protein 
structure is.  This analysis is reliant on the reference structures having normal geometric 
quality.    The  summary  of  Ramachandran  statistics  for  the  residues  (excluding  all 
prolines and glycine residues) of the ensemble of hMBD1 CXXC1 structures is shown in 
table 5.2 and the plots shown in appendix B. Greater than 90% of the residues fall within 
most favorable and additionally allowed regions.  This is indicative of a structure with a 
good geometric quality.  The contribution of unfavorable φ and ψ angles (Appendix B, 
figure b2a-c) in the unstructured N- (163-174) & C- (217-222) termini as well as the 
poorly defined loop region (197-207) results in higher than average number of residues 
in the disallowed region.  This is due to a lack of restraints to define these regions of the 
domain.  If the unstructured regions are removed from the Ramachandran analysis, the 
percentage of residues in the disallowed regions is significantly reduced.      
 
Regions of Ramachandran plot   % residues 
       Residues in most favoured regions  61.3% (77.7%) 
       Residues in additional allowed regions  32.3% (21.0 %) 
       Residues in generously allowed regions  3.3% (0.7%) 
       Residues in disallowed regions  3.1% (0.7%) 
 
Table 5.2  Summary of the Ramachandran statistics for the ensemble of 25 hMBD1 
CXXC1 structures.  Percentage in brackets indicates statistics for well defined regions 
only (residues 175-196:208-216) 
 
 
The geometric quality of a structure can also be analysed by the distribution of side 
chain torsion angles χ1.  This is the angle of N-Cα-Cβ-Xγ1 about the Cα-Cβ bond.   The 
distribution of side chains in hMBD1 CXXC are relatively well defined with no residue 
lying in unfavourable regions (appendix B2d-e). 
 
Table 5.3 lists the statistics of experimental restraints used for calculating the structure 
of hMBD1 CXXC1.  Total number of NOEs represents NOEs merged from the three 
NOESY spectra.  The constraint violations and R.M.S deviation data refers to 20 lowest 
energy structures from 25 water refined structures calculated.                                                                                                                                                  101 
NMR Dist NMR distance restraints 
Total NOE  1327 
       Ambiguous (main contributors)  593 
             Intra-residue  204 
             Inter-residue   
                  Sequential (i-j=1)  156 
                  Short range (i-j= >1 <4)  118 
                  Long range (i-j>5)  115 
       Unambiguous  734 
             Intra-residue  334 
             Inter-residue   
                  Sequential (i-j=1)  211 
                  Short range (i-j= >1 <4)  102 
                  Long range (i-j>5)  87 
Constraint Violations per structure   
       >0.5 Å (+/- SD)  0.10 (+/- 0.06) 
       >0.3 Å (+/- SD)  1.35(+/- 0.16) 
       >0.1 Å (+/- SD)  19.05 (+/- 0.81) 
R.M.S. deviations from the ideal geometry   
       Bond length (Å)    0.0038 (+/- 0.000023) 
       Bond Angle (º)  0.600 (+/- 0.05) 
       Improper angles (º)  1.476 (+/- 0.04) 
       Dihedrals (º)  42.17 (+/- 0.137) 
 
Table 5.3  Experimental restraint statistics for hMBD1 CXXC1 
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5.2 Structural features of the hMBD1 CXXC1 zinc binding motifs 
The solution structure of MBD1 CXXC1 adopts a crescent shape incorporating two zinc 
ions (figure 5.3).  Four cysteines provide the ligands for the coordination of each zinc 
ion,  three  from  each  CXXCXXC  motif.    The  main  chain  loops  back  180º  after  the 
second CXXCXXC motif to providing the fourth cysteine in each case.  The overall 
structure of the domain is governed by the presence of the two zinc clusters.  The zinc 
clusters have similar structures to each other with a backbone RMSD of 0.86 Å over the 
CXXCXXC sequence (calculated using Superpose. Maiti et al, 2004) and form a small 
helical turn between the first and second cysteines followed by a single turn of alpha 
helix, that includes residues 180A-183Q cluster 1 (figure 5.4a) and 192S-196L cluster 2 
(figure 5.4b).  However, the two CXXCXXC motifs appear to differ with respect to their 
side chain χ1 dihedral angles (Figure 5.3c).  This is consistent over the ensemble.  The χ1 
dihedral  angles  could  be  determined  from  J  couplings  determined  from  an  HNHB 
experiment:     
 
 
 
 
Figure 5.3  A stereo view of the representative structure of the closest to the mean 
structure of the 25 calculated hMBD1 CXXC1 solution structures.  The zinc atoms are 
shown as gray spheres; alpha helix are shown in red and green; N, N-terminus; C, C-
terminus (Figure prepared using PyMol).  
 
N 
C                                                                                                                                                103 
 
 
 
Figure 5.4  Stereo representation of the two cysteine zinc clusters from hMBD1 
CXXC1 (A) First CXXCXXC motif, residues 176-183 & 215  (B) Second CXXCXXC,  
motif residues 188-194 & 210  (C) superposition of the two CXXCXXC motifs. Sulphur 
atoms, yellow; zinc atoms, white (Figure prepared using PyMol). 
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Figure 5.5  Stereo representation of the structural alignment of (A) hMBD1 CXXC1 
residues 176-183 & 215 (red) and hMLL CXXC residues 1155-1162 & 1194 (blue). (B) 
hMBD1 CXXC1 residues 188-194 & 210 (green) and the hMLL CXXC residues 1167-
1175 & 1189 (cyan).  White spheres, hMBD1 CXXC zinc atom; gray spheres, hMLL 
CXXC zinc atom. (Figure prepared using PyMol) 
 
The zinc clusters from hMBD1 CXXC1 have a fold which is very similar to the zinc 
clusters from hMLL CXXC (Figure 5.5).  Backbone RMSDs of 1.12 Å and 0.46 Å were 
calculated  using  Superpose  (Maiti  et  al,  2004)  for  the  first  and  second  CXXCXXC 
motifs  respectively.    A  search  of  the  structural  data  base  http://www.ebi.ac.uk/pdbe-
site/pdbemotif/ for proteins that co-ordinate zinc by four cysteine residues revealed 62 
structures.    However,  nine  of  these  structures  use  two  separated  CXXC  motifs  to  
coordinate the zinc atom rather than the CXXCXXC motif found in hMBD1 CXXC1 
and  MLL  CXXC.    Alignment  of  the  CXXC  motifs  found  in  the  pdbe  database  to 
residues  179-182,  182-185,  188-191  and  191-194  hMBD1  CXXC1  reveals  a  highly 
similar backbone conformation with a pairwise RMSD 0.77 Å (±0.33).  Three structures 
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where found with a CXXCXXC motif: horse liver alcohol dehydrogenase (PDB - 1N8K) 
(Rubach & Plapp, 2003); E.coli RecQ helicase (PDB – 1OYW) (Bernstein et al, 2003) 
and the delta subunit of the clamp loader complex of E. coli DNA polymerase III (PDB 
– 1A5T) (Guenther et al, 1997).  The horse liver dehydrogenase has the fourth cysteine 
C-terminal to the CXXCXXC motif like hMBD1 CXXC1 and unlike the RecQ helicase 
and delta subunit of the clamp loader complex of E. coli DNA polymerase III in which it 
is N- terminal to the CXXCXXC motif.  Table 5.4 shows the pairwise RMSD for the 
CXXCXXC  motifs  of  hMBD1  CXXC1  and  the  other  CXXCXXC  motifs  described 
above.  Figure 5.7 shows the superposition of the CXXCXXC motifs from horse liver 
alcohol dehydrogenase, E.coli RecQ helicase, delta subunit of the clamp loader complex 
of E. coli DNA polymerase III and the second CXXCXXC motif from hMBD1 CXXC1  
 
  1N8K 97-103  1A5T 59-65  1OYW 397-403 
hMBD1 176-182  0.85 Å  0.98 Å  0.95 Å 
hMBD1 188-194  0.39 Å  0.49 Å  0.51 Å 
 
Table 5.4  Pairwise  backbone  RMSD  of  CXXCXXC  motifs  compared  to  the 
CXXCXXC  motifs  from  hMBD1  CXXC1  domain.  1N8K,  horse  liver  alcohol 
dehydrogenase;  1A5T,  delta  subunit  of  the  clamp  loader  complex  of  E.  coli  DNA 
polymerase III; 1OYW, E.coli RecQ helicase. 
 
A common feature of all the CXXCXXC motifs of known structure is a glycine residue 
following the first cysteine.  Preference for glycine at this position may be due to the 
requirement for a positive phi angle following the first cysteine.  The CXXCXXC motif 
has a characteristic helical turn between the 1
st and 2
nd cysteines, similar to that of the 
single CXXC motif, before an alpha helix incorporating the 3
rd cysteine (figure 5.6).  
Mutations of one of the zinc coordinating cysteines will destabilise the structure of the 
MLL  CXXC  domain  (Allen  et  al,  2006.  Cierpicki  et  al,  2009),  MBD1  CXXC3 
(Stancheva et al, 2010) and CGBP (Skalnik et al, 2001) suggesting the CXXCXXC 
motifs are absolutely required for maintaining the structure of the domain. 
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Figure  5.7  Stereo  view  of  the  superposition  of  CXXCXXC  motifs  from  hMBD1 
CXXC1 (red), horse liver dehydrogenase (black), E.coli RecQ helicase (blue), and the 
delta  subunit  of  the  clamp  loader  complex  of  E.  coli  DNA  polymerase  III  (green).  
Cystine side chains shown as sticks, sulphur atoms in yellow.  
 
5.3 hMBD1 CXXC1 does not bind CpG DNA 
Previous DNA binding experiments (EMSA) have shown hMBD1 CXXC1 not to bind 
CpG DNA.  However, DNA titration by NMR would show weak binding that might not 
be observed by EMSA.  Although chemical shift perturbation analysis by 
15N HSQC 
does not require the structure to be known, the assignment of spectrum crosspeaks is 
required to know which residues are affected by the titration of DNA.  When DNA is 
titrated into a protein sample a change in chemical shift will be recorded for any amino 
acid that is affected by the binding of the protein to DNA.  This change in chemical shift 
of a residue is due to an environmental change that may be due to direct interaction with 
the DNA or a resultant conformational change of the protein.                                                                                                                                                    107 
5.3.1 
15N  HSQC  DNA  titration  of  hMBD1  CXXC1  reveals  no  protein  DNA 
interaction 
The titration of hMBD1 CXXC1 with DNA measured by 
15N HSQC is shown in figure 
5.8.  There is little or no chemical shift perturbation with 3 fold excess DNA for the 
assigned  resonances  suggesting  that  hMBD1  CXXC1’s  Kd  for  DNA  is  significantly 
above 150 µM.  However, small chemical shift perturbations are seen for the unassigned 
spin system 435 and the minor form A1203.  Resonance A1203 was assigned as the 
minor form of A203 as they share the same Hα and Hβ chemical shifts.  It is likely that 
resonance 435 is also from a minor form and since perturbation is only visible at the 3 
fold excess DNA concentration, this suggests non-specific DNA binding.  The minor 
form resonance A1203 is also only visible at the 3 fold excess DNA concentration.  This 
is likely due to unfolding or degradation of the protein during the course of the titration.  
Intensity differences are seen for glycine 165 and the side chain Nɛ of arginine 214.  
These highly solvent exchangeable resonances appear to be very sensitive to sample 
conditions  since  their  intensities  vary  considerably  from  sample  to  sample.    It  is 
therefore likely that the effect seen here is not  DNA-specific, but rather reflects small 
differences in ionic strength.  The lack of chemical shift perturbation that suggests no 
protein  DNA  interaction  is  consistent  with  the  findings  of  Fujita  et  al  (2000)  and 
Jorgensen et al (2004) who observed no DNA shift in electrophoresis mobility shift 
assay experiments. 
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5.3.2 Why does hMBD1 CXXC1 not bind DNA? 
The MLL CXXC (Lee et al, 2001), MBD1 CXXC3 (Bird et al, 2004) , CGBP CXXC 
(Skalnik et al, 2001) and DNMT1 CXXC (Meehan et al, 2008., Pradhan et al, 2008.) 
have been shown to bind CpG DNA and therefore a comparison of the known DNA 
binding CXXC structures with that of hMBD1 CXXC1 should provide an insight as to 
why hMBD1 CXXC1 does not bind CpG DNA.  The solution structure of MLL CXXC 
(Cierpicki et al, 2008) and the X-ray crystal structure of DNMT1 CXXC (Song et al, 
2010) in complex with CpG containing DNA reveal that the positively charged face of 
the domain binds to the target DNA major groove.   
 
The MLL CXXC domain binds the CpG motif in the major groove though formation of 
hydrogen bonds to the CpG.  Using the terminology of Cierpicki et al (2009), the N4-
amine  groups  of  the  negative  and  positive  stand  cytosines  hydrogen  bond  to  the 
backbone oxygen of K1185 and K1186 respectively.  The side chain of K1186 forms 
hydrogen bonds to the negative strand guanine while the side chain amide of Q1187 
hydrogen bonds to positive strand guanine (Cierpicki et al, 2009).  Cierpicki et al (2009) 
also discovered weak NOEs between the side chains of R1150, S1152 and L1197 and 
the DNA minor groove and mutation of R1150 and L1197 to alanine resulted in a 5 and 
4  fold  reduction  in  DNA  binding  affinity  respectively.    DNA  binding  domains  are 
generally evolved to contain positively charged amino acids though which they contact 
the negatively charged DNA phosphate backbone (Jones et al, 2003) while the shape of 
the DNA binding face is often complementary to the DNA duplex surface (Tsuchiya et 
al, 2004).   hMLL CXXC has made electrostatic interactions to the DNA and residues 
R1154, K1176, K1178, K1185, K1190, R1192, K1193.   
 
Table 5.5 show the corresponding residues from hMBD1 CXXC1 and xDNMT1 CXXC. 
hMBD1 CXXC1 differs from hMLL CXXC in many of the residues required for CpG 
DNA  binding,  not  only  in  the  residues  that  hydrogen  bond  to  the  CpG  but  also  in 
residues involved in electrostatic interaction.  In addition to electrostatic interactions and 
hydrogen  bonds,  repulsive  forces  between  the  protein  and  DNA  may  reduce  or 
ultimately  abolish  DNA  binding.    Mutation  of  residue  1188  from  a  cysteine  to  an 
aspartate in hMLL CXXC is sufficient enough to abolish detectable DNA binding as 
mentioned by NMR.   
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hMLL CXXC  hMBD1 CXXC1  xDNMT1 CXXC 
R1150  R161  E516 
S1152  A163  N518 
R1154  N165  I520 
K1176  Q197  M546 
K1178  P199  K548 
K1185  L206  T555 
K1186  F207  K556 
Q1187  C208  Q557 
K1190  E211  M560 
R1192  R213  R562 
K1193  R214  563 
L1197  I218  L567 
   
Table 5.5  List  of  residues  involved  in  electrostatic  interaction  with  DNA  from 
hMLL  CXXC1  (Cierpicki  et  al,  2009)  and  the  corresponding  residues  in  hMBD1 
CXXC1 and xDNMT1 CXXC. Residues mutated to alanine that abrogate DNA binding 
shown in bold, mutated residues that still bind DNA shown in blue.  
 
A surface charge plot of hMBD1 CXXC1 was produced using the Adaptive Poisson-
Boltzmann Solver (APBS) plugin in PyMol reveals a positive charge surrounding the 
first  CXXCXXC  motif  while  the  second  CXXCXXC  motif  and  loop  region  has  an 
overall negative charge.  This contrasts with the positive charged face of hMLL CXXC 
domain (figure 5.9).  In conclusion hMBD1 CXXC does not bind DNA because lacks 
the residues that are important for hydrogen bonding and has a slightly negative charged 
face compared to the strongly positively charged face of hMLL CXXC. 
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Figure 5.9  Stereo representation of the electrostatic surface potential of the hMBD1 
CXXC1 (A) and hMLL CXXC (B). Coloured using a linear colour ramp from -75.0 KT 
hMLL (red) to +75hMLL (blue).  (Figure prepared using the APBS plugin in PyMol) 
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5.4 Comparison of the loop region of hMBD1 CXXC1 and hMLL CXXC 
Currently the RCSB protein data bank contains three CXXC domain structures which 
are those of the hMLL CXXC domain (Allen et al, 2006., Cierpicki et al, 2008) and the 
DNMT1 CXXC (Song et al, 2010).  Figure 5.10 illustrates the structural superposition of 
hMBD1 CXXC1 with hMLL CXXC (PDB ID 2J2S) that has a pair wise RMSD of 1.83 
Å over the well defined regions of hMBD1 CXXC (residues 175-196 & 208-217).  The 
loop region residues 197-207 is not well defined in the  hMBD1 CXXC1 ensemble due 
to a lack of long range NOEs, whereas the loop region in hMLL CXXC is well defined 
in the NMR ensemble.     
  
 
 
Figure 5.10  Structural  superposition  of  hMBD1  CXXC1  R169-S221  (blue)  and 
hMLL CXXC S1152-W1196 (green), PKFGG loop (pink); red spheres hMBD1 CXXC 
zinc; black spheres hMLL CXXC zinc.  N, N-terminal; C, C-terminal (Figure prepared 
using PyMol) 
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C                                                                                                                                                113 
A motif conserved in CpG DNA binding CXXC domains but not present in hMBD1 
CXXC1 (or hMBD1 CXXC2) is the KFGG motif (figure 5.11).  In hMBD1 CXXC1 the 
corresponding sequence is PHDV which has a significant effect on the structure of the 
loop region since compared with the phenylalanine the histidine is less hydrophobic and 
partially positively charged it is not able to be tightly packed into the main chain. The 
kink in the backbone (figure 5.12) due to the presence of a proline preceding the H200 
does not allow the hydrophobic side chain to pack up against β protons of cysteine 194, 
where  as  the  proline  in  hMLL  CXXC  is  two  residues  before  the  phenylalaine.      In 
DNMT1 CXXC the KFGG sequence is preceded by a lysine rather than the proline in 
the MLL CXXC domain.   
 
 
 
Figure 5.11  Comparison  of  second  CXXCXXC  motif  &  N-terminus  of  the  loop 
region of hMBD1 CXXC1 C188 to V202 (A) and hMLL CXXC C1176 to G1181 (B) 
residues. N, N-terminal; C, C-terminal (Figure prepared using PyMol) QLPHD 
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Figure 5.12  Stereo representation of the structural superposition of hMBD1 CXXC1 
C188-V202  and  hMLL  CXXC  C1176-G1181.  N,  N-terminal;  C,  C-terminal  (Figure 
prepared using PyMol) 
 
The solution structure ensemble of xDNMT1 CXXC (Thomson & Smith, unpublished) 
has a less well defined loop region than hMLL CXXC, therefore proline 1177 maybe 
required  for  loop  stability.    Mutation  of  hMLL  CXXC  residues  K1178  or  F1179  to 
alanine significantly reduced the ability to bind a 12bp single CpG DNA in an EMSA 
(Allen et al, 2006).   These mutations of hMLL CXXC indicate that the precise, and 
ordered structure of this loop be required for efficient DNA binding. 
 
5.5 Conclusion 
The  solution  structure  of  hMBD1  CXXC1  presented  in  this  thesis  shows  both 
similarities and differences to the known structures of hMLL CXXC (Allen et al, 2006) 
and DNMT1 CXXC (Song et al, 2010., Thomson & Smith, unpublished).  The two zinc 
coordinating  cysteine  clusters  of  the  CXXCXXC  domain  form  a  common  structure 
shared with both hMBD1 and DNMT1 CXXC.  This fold is highly likely to be common 
N 
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D201 
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to other CXXCXXC domains.   
However, hMBD1 CXXC1 lacks the KFGG motif which is present in the non-methyl 
CpG binding CXXCXXC domains.  The KFGG motif forms  a small  helix after the 
second CXXCXXC motif which appears to stabilise the DNA binding loop.  Mutations 
in this region have been shown to reduce DNA binding (Allen et al, 2006).  hMBD1 
CXXC1 also differs from other CXXCXXC domains by lacking residues important for 
DNA binding.  These differences not only change the surface charge of the loop thus not 
attracting  the  DNA  through  charge-charge  interaction  but  lack  the  side  chains  to 
hydrogen  bond  to  the  DNA  bases.    The  function  of  hMBD1  CXXC1  is  currently 
unknown although it has been shown to bind residues 250-337 of Ring1b (Min et al, 
2003).    Ring1b  is  a  component  of  the  Polycomb  group  (PcG)  multiprotein  PRC1 
complex (Min et al, 2003) which is required to maintain the transcriptionally repressive 
state of many genes.  Since hMBD1 CXXC3 does not interact with Ring1b that suggests 
the difference in the loop region of hMBD1 CXXC1 may be involved in the protein 
interaction with ring1b. 
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CHAPTER SIX 
 
NMR STUDY OF hMBD1 CXXC12 
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6.1 Overview 
The first two MBD1 CXXC domains lack the consensus sequence DXXKFGG and have 
been shown not to bind CpG DNA (Jorgensen et al. 2004).  The function of this pair of 
domains is still unknown although it has been shown to bind AA 250-337 of Ring1b 
(Sakamoto et al, 2007) suggesting a role in recruitment of the polycomb repressor 
complex 1 (PRC1) to DNA for maintenance of transcriptional repression.  hMBD1 
CXXC12 has also been shown to interact with the HMT SETDB1 and CAF150 in 
association with the MBD and TRD (Sarraf & Stancheva, 2004)  
 
With the structure of the first MBD1 CXXC domain known, I wish to ask wither the 
presence of the second MBD1 CXXC domain affects the 3D structure of hMBD1 
CXXC1?  Should the two CXXC domains interact, we would expect to see chemical 
shift perturbation for residues whose environment has been affected by the presence of 
the second CXXC domain.  Changes in the extreme C-terminal region of CXXC1 are 
also likely since this area should be more structured in the presence of CXXC2.   There 
may also be chemical shift changes for resonances assigned to the loop or well defined 
regions of CXXC1 if the CXXC2 domains interact more extensively.  
 
6.2 Cloning, expression of hMBD1 CXXC12 
Using the previously described pGEX 6P1 expression and purification system, PCR 
amplification of DNA containing the CXXC1 & CXXC2 of hMBD1 was performed 
using the primers shown in table 6.1.  The resultant fragment was cloned into pGEM T-
easy vector and subcloned into pGEX 6P1 as previously described in chapter 2.   The 
PCR (Figure 6.1), cloning into pGEM T-easy (Figure 6.2) and subcloning into pGEX 
6P1 (Figure 6.3) are shown below. Plasmids were sequenced to make sure no errors 
were present. 
 
 
hMBD1 CXXC1 fwd  5’ GGGATCCGAGCAGAGAATGTTTAAG 3’ 
hMBD1 CXXC2 rev 5’  CCTCGAGTTCAGCGGGCATGTTTA 3’ 
 
Table 6.1  Primers used for the PCR amplification of hMBD1 CXXC12.   
Restriction enzyme sites shown in bold & stop codon underlined.                                                                                                                                                118 
 
The amino acid sequence of the expressed hMBD1 CXXC12 construct is shown in table 
6.2 which has a predicted molecular weight of 11.8 kDa.   Based on the structured region 
of hMBD1 CXXC1 it is likely the two domains are separated by a small linker sequence.   
 
 
GSEQRMFKRVGCGECAACQVTEDCGACSTCLLQLPHDVASGLFCKCERRRCL 
RIVERSRGCGVCRGCQTQEDCGHCPICLRPPRPGLRRQWKCVQRRCLRGKHAR 
 
 
Table 6.2 Amino acid sequence of the cloned hMBD1 CXXC12 domain.  The structured 
domain of CXXC1 is shown in red, the CXXC2 sequence shown in blue with the 
putative linker sequence underlined.    
 
                         
                             M                 1 
Figure 6.1  Agarose gel electrophoresis image hMBD1 CXXC12 PCR product. M – 
100bp DNA marker NEB (N3231), 1 – hMBD1 CXXC12 arrow indicated band of 
interest 
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300bp                                                                                                                                                119 
500bp 
1 kb 
                             
Figure 6.2  Agarose gel electrophoresis of a selection of 2 putative pGEM-T hMBD1 
CXXC12 clones digested with BamH1 and Xho1. 1 - 1KB ladder NEB, 2 - 100bp ladder 
NEB, 3-4 putative pGEM-T hMBD1 CXXC12 clones.  Arrow indicates band of correct 
size for CXXC12 insert. Lane 4 show the expected fragment pattern 
 
                              
 
Figure 6.3   Agarose gel electrophoresis of a selection of 2 putative pGEX6P1-
hMBD1 CXXC12 clones digested with BamH1 and Xho1. The arrow indicates the 
expected position of the CXXC12 fragments. Clones 1 & 2 show the expected fragment 
pattern.  M- Bioline hyperladder 1 
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6.3 Purification of hMBD1 CXXC12 
Purification of hMBD1 CXXC12 was carried out using the method described in chapter 
2.  Figure 6.4 illustrates the purification of hMBD1 CXXC12.  The preparation of 
hMBD1 CXXC12 was hampered by precipitation of the purified protein during 
overnight cleavage of the tag.   The protein sample suffered further precipitation during 
buffer exchange and concentration thus making it difficult to produce sufficient quantity 
for isotopic labeling in an economic way. 
 
                 
                   1          2    3     4        5         6                7 
Figure 6.4   SDS-PAGE analysis of the expression and purification of hMBD1 
CXXC12 domain expressed in Tuner
TM DE3 cells. 1 – NEB prestained protein marker 
(cat. No. P7708S) , 2 – 5 l whole cell fraction, 3 – 5 l of soluble fraction, 4 – 5µl of 
flow through, 5 – 20µl of resin before Pre-Scission protease treatment, 6 – 20 µl resin 
after Pre-Scission protease treatment, 7– 20 l elution of hMBD1 CXXC12 domain.    
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6.4 NMR studies of hMBD1 CXXC12 
During long NMR experiments hMBD1 CXXC12 would degrade & precipitate.  This 
coupled with the lack of economic viability to express isotopically labelled protein 
meant that at this time it was only possible to record homonuclear experiments.  Shown 
in table 6.3 are the NMR experimental parameters for the 2D 
1H NOSEY experiment7 
 
 
Table 6.3  Acquisition parameter of NMR experiment on hMBD1 CXXC12 (Bruker 
AVANCE 600 MHz) used for resonance assignment and structural restraints collection. 
Nuc: Nucleus, TD: time domain points (complex), SW: sweep width in Hz, RD: 
relaxation delay, NS: number of scans, WS: water suppression, ES: excitation sculpting, 
ms: milliseconds, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    F1      F 2         
Experiment  Nuc  TD  SW  Nuc  TD  SW  RDms  NS  WS 
100ms 
NOSEY 
1H  2048  8503 
1H  1700  7001  1.0  32  ES                                                                                                                                                122 
6.4.1 Is hMBD1 CXXC12 structured?  
To asses the quality of the CXXC12 sample, a 1D 
1H experiment was carried out to 
investigate if the purified hMBD1 CXXC12 protein was structured.  The recorded 1D 
1H 
spectrum of hMBD1 CXXC12 is shown in figure 6.5 
 
 
Figure 6.5  1D 
1H spectrum of unlabeled hMBD1 CXXC12 (10mM dTris, 250mM 
NaCl, pH 7.5, 293K).  Water suppression using the method of Hwang and Shaka (1995) 
 
The 1D 
1H spectrum of unlabeled hMBD1 CXXC12 suggests that the protein sample is 
folded due to the overall dispersion of chemical shifts and the 
1H line widths.  The  
region of the spectrum around 10 ppm shows peaks clearly not present in the 1D 
1H 
spectrum of CXXC1 while the peak around 0.5 ppm is still present.  Also the 6.5-8.5 
ppm region for CXXC12 is not as intense compared to the same region in CXXC1 
suggesting that fewer residues are in unstructured highly dynamic conformations.   
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6.4.2 Is CXXC1’s structure affected by the presence of CXXC2? 
A 2D homonuclear NOESY experiment was carried out in order to compare the 
spectrum with the 2D NOESY of hMBD1 CXXC1.  Figure 6.6 shows the Hα-HN region 
of hMBD1 CXXC12 & CXXC1 with the overlaid HN-HN region in figure 6.7.  Since the 
sample precipitated during the course of the experiment further 2D spectra that would 
present a more complete analysis could not be recorded. 
 
 
 
 
Figure 6.6   HN-Hα region of the 2D homonuclear spectra of hMBD1 CXXC1 (black) 
and hMBD1 CXXC12 (pink) overlaid (10mM dTris, 250mM NaCl, pH 7.5, 293K).  
Examples of assigned crosspeaks which have changed chemical shifts are indicated. 
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Figure 6.7  HN-HN region of the 2D homonuclear spectra of hMBD1 CXXC1 (black) 
and hMBD1 CXXC12 (pink) overlaid (10mM dTris, 250mM NaCl, pH 7.5, 293K).  
Examples of assigned crosspeaks which have changed chemical shifts are indicated.   
 
However, from a comparison of the CXXC12 & CXXC1 spectra it is clear that certain 
CXXC1 amino acids have altered chemical shift in CXXC12.  The most notable changes 
are seen in the dynamic loop region of CXXC1with amino acids S204 and P207, while 
others such as C179, A190 & T193 show no chemical shift change.  These chemical 
shift changes indicate a change in environment of the loop region suggesting that it is 
possibly in close proximity to the second CXXC domain.  In the loop region there are 
changes between the two constructs with the Hβ protons of C208 no longer correlated to 
the Hγ of T193 in CXXC12 while previously strong cross peaks have reduced intensity 
e.g. E211 γ protons correlation to C191 β protons.  These NOE changes in the loop 
region suggest the second CXXC domain is changing the shape of the loop region.  
Residues C179, A190, & T193 are found within the zinc clusters and seem to be 
unaffected by the presence of the second CXXC domain.  Residues at the extreme C-
terminus, amino acids 219-222, are unstructured when hMBD1 CXXC1 is expressed on 
δ 
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its own.  However, in hMBD1 CXXC12, their NOE cross peaks shift or disappear. 
Certain clearly identifiable crosspeaks in the CXXC1 2D NOESY such as the Hγ-HN of 
E220 and the sequential HN - HN & HN -Hα cross peaks for residues V219-R222 are 
absent or significantly shifted in the CXXC12 spectrum.  The lack of these NOE 
crosspeaks means that the structure of this region has changed in the CXXC12 construct.   
 
6.5 Conclusions 
Initial NMR experiments have shown that the expressed hMBD1 CXXC12 domains are 
structured in solution.  However, to carry out 3D NMR experiments to facilitate 
assignment and eventually structure calculations, protein purification conditions must be 
further optimized.  Changes to pH are limited with the use of PreScission protease due to 
a narrow functional pH range, but NaCl concentration can be adjusted up to 1 M.  
Therefore, it would be possible to significantly alter the salt concentration of the 
purification and NMR buffer in an attempt to prevent precipitation of the protein. 
 
Although the NOE data recorded is not sufficient to fully assign and calculate the 
structure of hMBD1 CXXC12, it is possible to suggest the relative orientation of the two 
CXXC domains.  There are significant NOE differences in the loop region (201N-209K) 
in hMBD1 CXXC12 to suggest there is a change in environment.  This may be due to 
the close proximity of the second CXXC domain.  In hMBD1 CXXC1 residues 216L-
222S are poorly constrained resulting in a flexible free end.  Therefore, it is unsurprising 
that there are chemical shift changed in this region since in hMBD1 CXXC12 they form 
a small interconnecting bridge between the two domains.  Due to the observed NOE 
changes it is likely that the two domains are folded together in one structure rather than 
two independent domains.  In order to verify this theory, recording 
15N relaxation data 
for both constructs would provide information as to the relative dynamics of the two 
domains domain.  If the structure of CXXC12 was as suggested by the homonuclear 
NOE data then the 
15N relaxation parameters recorded for each of the two domains 
would be quite similar and the T1/T2 ratios for CXXC12 should be indicative of an 
~12kDa globular species rather than independently tumbling ~6kDa species.  Should the 
precipitation problem with hMBD1 CXXC12 be overcome it will be possible to 
isotopically label the protein and carry out 3D NMR experiments.  It will also be 
possible to investigate the protein-protein interactions with amino acid 250-337 domain 
of ring1b (Sakamoto et al, 2007) with MBD1 CXXC12 once the domain is isotopically 
labelled.                                                                                                                                                          
  126 
Appendix A Laboratory buffers and methods 
 
Bacterial Growth Media 
Appropriate selection antibiotics were added in all media prior to use. 
 
LB Medium   1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% NaCl (w/v)  
5XM9 stock  3.4%  (w/v)  Na2HPO4,  1.5%  KH2PO4,  0.25%  (w/v)  NaCl, 
autoclaved prior to use 
M9 minimal medium for 500 ml; 100 ml 5XM9, 2 mM MgSO4, 0.1 mM CaCl2, 0.3% D-
glucose (w/v), 8 mM (NH4)2SO4, 0.004% thiamine (w/v) 
Labelled medium  For 
15N labelling, replace 8 mM (NH4)2SO4 with 16 mM 
15NH4Cl 
(Isotec, 11186AE).  
 
GST purification buffers 
Lysis/binding buffer  10× PBS: 1.4 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 18 mM 
KH2PO4, pH 7.3.  Use at 1x 
PreScission buffer  50 mM  Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM DTT 
Elution buffer   300 mM NaCl, 2.7 mM KCL, 10 mM Na2HPO4, 1.8mM KH2PO4, 
1 mM DTT, pH 7.3 
 
Bradford assay 
The protein concentration was measured using Bradford assay kit brought from Pierce 
(Product  No.  23236).  The  measurement  was  performed  according  to  the  standard 
protocol in the manufacturer's instructions. 
 
SDS-PAGE 
Coomassie Stain  45%  methanol,  45%  dH2O,  10%  acetic  acid,  0.25%  (w/v) 
coomassie R250  
Destain Buffer  5% methanol, 10% acetic acid, 85% dH2O   
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Appendix B Ramachandran  plots,  χ1torsion  angle  distributions  and 
average  secondary  structure  for  the  final  ensemble  of  hMBD1  CXXC 
structures.  Structural analysis by Procheck-NMR 
 
Figure B.1  Graphical  summary  of  Ramachandran  statistics  for  the 
final ensemble of 25 hMBD1 CXXC structures.                                                                                                                                               
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Figure B.2 Per-residue Ramachandran plots for the final ensemble of 20 hMBD1 
CXXC1 structures.  Yellow boxes indicated favourable and red boxes indicate 
unfavorable φ, ψ dihedral angle combinations.  
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Figure  B.2b  Per-residue  Ramachandran  plots  for  the  final  ensemble  of  20 
hMBD1 CXXC1 structures.  Yellow boxes indicate favourable and red boxes 
indicates unfavorable φ, ψ dihedral angle combinations respectively.                                                                                                                                                
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Figure  B.2c  Per-residue  Ramachandran  plots  for  the  final  ensemble  of  20 
hMBD1 CXXC1 structures.  Yellow boxes indicate favourable and red boxes 
indicates unfavorable φ, ψ dihedral angle combinations respectively.                                                                                                                                               
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Figure B.2d Per-residue X1 frequency plots for the final ensemble of 20 hMBD1 
CXXC1 structures.  Yellow boxes indicated favorable and red boxes indicates 
unfavourable φ, ψ dihedral angle combinations.  
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Figure B.2e Per-residue X1 frequency plots for the final ensemble of 20 hMBD1 
CXXC1 structures.  Yellow boxes indicated favorable and red boxes indicates 
unfavourable φ, ψ dihedral angle combinations.  
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Figure B.2d Average secondary structure and accessibility plot for the final ensemble of 
25 hMBD1 CXXC1 structures  
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Appendix C  Chemical  shift  assignments  of  hMBD1  CXXC1.    Chemical  shifts  are  given  in  p.p.m,  no  chemical  shift  indicates  unassigned  or 
unobserved resonances 
Residue  H  N  NE  NZ  NH  HA  HB  HG  HD  HE  HZ 
163Pro  -  -  -  -  -  4.46  1.92,2.30  1.99,1.99  3.56,3.56     
164Leu  8.6  122.72  -  -  -  4.34  1.57,1.59  1.66  0.87,0.91  -  - 
165Gly  8.56  110.52  -  -  -  3.95,4.05  -  -  -  -  - 
166Ser  8.24  123.15  -  -  -  4.35  3.82,3.89  -  -  -  - 
167Glu  8.62  122.8  -  -  -  4.2  1.95,2.02  2.26,2.20  -  -  - 
168Gln  8.28  120.76  112.84  -  -  4.2  1.96,2.07  2.34,2.34  -  7.59,6.90  - 
169Arg  8.24  121.54  -  -  -  4.21  1.73,1.73  1.51,1.57  3.14,3.14  -  - 
170Met  8.19  -  -  -  -  4.38  1.91,1.92  2.47,2.39  -  -  - 
171Phe  8.17  121.09  -  -  -  4.59  3.12,2.96  -  7.19  7.3  - 
172Lys  8.15  122.49  -  -  -  4.21  1.75,1.67  1.37,1.31  1.63,1.63  2.93,2.94  - 
173Arg  8.24  122.47  -  -  -  4.31  1.81,1.75  1.57,1.62  3.15,3.15  -  - 
174Val  8.24  121.19  -  -  -  4.2  2.09  0.94,0.94  -  -  - 
175Gly  8.34  111.29  -  -  -  4.06,4.14  -  -  -  -  - 
176Cys  9.36  126.38  -  -  -  4.48  2.80,3.25  -  -  -  - 
177Gly  9.55  115.33  -  -  -  3.83,4.35  -  -  -  -  - 
178Glu  9.62  123.72  -  -  -  4.57  1.93,2.06  2.15,2.22  -  -  - 
179Cys  7.12  120.34  -  -  -  4.7  2.98,3.46  -  -  -  - 
180Ala  8.84  120.15  -  -  -  3.95  1.42  -  -  -  - 
181Ala  7.39  120.51  -  -  -  4.4  1.28  -  -  -  - 
182Cys  8.57  120.38  -  -  -  4.05  2.92,2.95  -  -  -  - 
183Gln  7.44  114.45  111.92  -  -  4.11  1.88,1.87  2.34,2.25  -  7.02,6.69  - 
184Val  7.21  122.55  -  -  -  3.92  2.25  1.19,1.02  -  -  - 
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Appendix C  Chemical  shift  assignments  of  hMBD1  CXXC1.    Chemical  shifts  are  given  in  p.p.m,  no  chemical  shift  indicates  unassigned  or 
unobserved resonances 
Residue  H  N  NE  NZ  NH  HA  HB  HG  HD  HE  HZ 
185Thr  8.57  116.22  -  -  -  4.37  4.42  1.19  -  -  - 
186Glu  7.1  119.02  -  -  -  4.6  1.96,1.77  1.99,2.16  -  -  - 
187Asp  8.78  124.9  -  -  -  4.5  2.42,3.47  -  -  -  - 
188Cys  9.39  127.21  -  -  -  4.47  3.29,2.84  -  -  -  - 
189Gly  9.52  115.74  -  -  -  4.19,3.89  -  -  -  -  - 
190Ala  9.95  127.56  -  -  -  4.61  1.35  -  -  -  - 
191Cys  7.06  119.33  -  -  -  4.85  3.40,2.97  -  -  -  - 
192Ser  9.01  114.78  -  -  -  4.81  3.99,4.03  -  -  -  - 
193Thr  7.89  117.58  -  -  -  4.01  4.26  1.04  -  -  - 
194Cys  9.01  126.91  -  -  -  3.96  2.98,2.92  -  -  -  - 
195Leu  8.03  116.75  -  -  -  4.08  1.63,1.62  1.46  0.70,0.80  -  - 
196Leu  7.42  119.34  -  -  -  4.17  1.87,1.87  1.5  0.84,0.92  -  - 
197Gln  7.92  117.57  112.73  -  -  4.15  2.08,2.02  2.31,2.32  -  6.86,7.53  - 
198Leu  8.32  122.95  -  -  -  4.52  1.60,1.41  1.64  0.90,0.91  -  - 
199Pro  -  -  -  -  -  4.39  1.86,2.30  2.02,2.02  3.84,3.55  -  - 
200His  8.45  -  -  -  -  4.51  3.10,3.10  -  8.16  7.11  - 
201Asp  8.22  120.5  -  -  -  4.55  2.65,2.65  -  -  -  - 
202Val  7.93  120.82  -  -  -  3.93  2.08  0.92,0.92  -  -  - 
203Ala  8.31  124.63  -  -  -  4.23  1.39  -  -  -  - 
204Ser  7.98  113.35  -  -  -  4.32  3.89,3.86  -  -  -  - 
205Gly  8.13  110.16  -  -  -  3.87,3.96  -  -  -  -  - 
206Leu  7.89  121.02  -  -  -  4.2  1.44,1.43  1.34  0.74,0.81  -  7.23 
207Phe  8.07  119.02  -  -  -  4.53  2.97,3.12  -  7.18  7.29  -                                                                                                                                               
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Appendix C  Chemical  shift  assignments  of  hMBD1  CXXC1.    Chemical  shifts  are  given  in  p.p.m,  no  chemical  shift  indicates  unassigned  or 
unobserved resonances 
 
Residue  H  N  NE  NZ  NH  HA  HB  HG  HD  HE  HZ 
208Cys  8.13  120.23  -  -  -  4.38  2.71,2.78  -  -  -  - 
209Lys  8.15  123.48  -  -  -  4.19  1.58,1.65  1.36,1.37  1.58,1.58  2.90,2.90  - 
210Cys  8.56  125.58  -  -  -  3.87  2.91,2.30  -  -  -  - 
211Glu  9.31  112.13  -  -  -  3.8  2.27,2.10  2.48,2.70  -  -  - 
212Arg  9.09  119.51  -  -  -  4.35  2.06,2.11  1.83,1.83  3.29,3.24  -  - 
213Arg  7.54  114.39  83.8  -  -  4.66  1.42,2.38  1.91,1.29  3.11,3.11  6.83  - 
214Arg  6.77  120.46  84.52  -  -  4.04  1.63,1.77  1.51,1.84  3.15,3.19  6.67  - 
215Cys  8.23  126.72  -  -  -  3.89  2.98,2.76  -  -  -  - 
216Leu  9.08  110.46  -  -  -  4.31  1.78,1.84  2.11  0.98,1.15  -  - 
217Arg  9.33  121.68  -  -  -  4.38  1.95,1.81  1.69,1.58  3.31,3.28  -  - 
218Ile  7.54  121.04  -  -  -  4.15  1.85  1.12,1.50,0.85  0.82  -  - 
219Val  8.17  124.39  -  -  -  4.1  2.02  0.89,0.90  -  -  - 
220Glu  8.47  124.99  -  -  -  4.29  1.92,2.01  2.20,2.25  -  -  - 
221Arg  8.35  122.82  -  -  -  4.39  1.75,1.88  1.62,1.62  3.17,3.17  -  - 
222Ser  8.04  123.13  -  -  -  4.24  3.83,3.84  -  -  -   
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